<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Ultrafiltration for acute heart failure - Srivastava, M - 2022 | Cochrane Library</title> <meta content="Ultrafiltration for acute heart failure - Srivastava, M - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013593.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Ultrafiltration for acute heart failure - Srivastava, M - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013593.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013593.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Ultrafiltration for acute heart failure" name="citation_title"/> <meta content="Mehul Srivastava" name="citation_author"/> <meta content="mehulsri12@gmail.com" name="citation_author_email"/> <meta content="Nicholas Harrison" name="citation_author"/> <meta content="Indiana University School of Medicine" name="citation_author_institution"/> <meta content="Ana Francisca SMA Caetano" name="citation_author"/> <meta content="Royal Brompton and Harefield NHS Foundation Trust" name="citation_author_institution"/> <meta content="Audrey R Tan" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Mandy Law" name="citation_author"/> <meta content="Royal Melbourne Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD013593.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/01/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013593.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013593.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013593.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Heart Failure [therapy]; Renal Replacement Therapy; Respiration, Artificial; *Ultrafiltration" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013593.pub2&amp;doi=10.1002/14651858.CD013593.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013593\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013593\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013593.pub2",title:"Ultrafiltration for acute heart failure",firstPublishedDate:"Jan 21, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013593.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013593.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013593.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013593.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013593.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013593.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;riskOfBias2&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of Bias&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013593.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013593.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013593.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013593.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4118 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013593.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0067"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-sec-0061"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/appendices#CD013593-sec-0072"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2"> Risk of bias </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/table_n/CD013593StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/table_n/CD013593StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Ultrafiltration for acute heart failure</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#CD013593-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Mehul Srivastava</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#CD013593-cr-0005">Nicholas Harrison</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#CD013593-cr-0006">Ana Francisca SMA Caetano</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#CD013593-cr-0007">Audrey R Tan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information#CD013593-cr-0008">Mandy Law</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information/en#CD013593-sec-0076">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 January 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013593.pub2">https://doi.org/10.1002/14651858.CD013593.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013593-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013593-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013593-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013593-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013593-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013593-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013593-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013593-abs-0001" lang="en"> <section id="CD013593-sec-0001"> <h3 class="title" id="CD013593-sec-0001">Background</h3> <p>Pharmacotherapies such as loop diuretics are the cornerstone treatment for acute heart failure (AHF), but resistance and poor response can occur. Ultrafiltration (UF) is an alternative therapy to reduce congestion, however its benefits, efficacy and safety are unclear. </p> </section> <section id="CD013593-sec-0002"> <h3 class="title" id="CD013593-sec-0002">Objectives</h3> <p>To assess the effects of UF compared to diuretic therapy on clinical outcomes such as mortality and rehospitalisation rates. </p> </section> <section id="CD013593-sec-0003"> <h3 class="title" id="CD013593-sec-0003">Search methods</h3> <p>We undertook a systematic search in June 2021 of the following databases: CENTRAL, MEDLINE, Embase, Web of Science CPCI‐S and ClinicalTrials.gov. We also searched the WHO ICTRP platform in October 2020. </p> </section> <section id="CD013593-sec-0004"> <h3 class="title" id="CD013593-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared UF to diuretics in adults with AHF. </p> </section> <section id="CD013593-sec-0005"> <h3 class="title" id="CD013593-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial quality and extracted data. We contacted study authors for any further information, and language interpreters to translate texts. We assessed risk of bias in included studies using Risk of Bias 2 (RoB2) tool and assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD013593-sec-0006"> <h3 class="title" id="CD013593-sec-0006">Main results</h3> <p>We included 14 trials involving 1190 people. We included people who had clinical signs of acute hypervolaemia. We excluded critically unwell people such as those with ischaemia or haemodynamic instability. Mean age ranged from 57.5 to 75 years, and the setting was a mix of single and multi‐centre. Two trials researched UF as a complimentary therapy to diuretics, while the remaining trials withheld diuretic use during UF. There was high risk of bias in some studies, particularly with deviations from the intended protocols from high cross‐overs as well as missing outcome data for long‐term follow‐up.  </p> <p>We are uncertain about the effect of UF on all‐cause mortality at 30 days or less (risk ratio (RR) 0.61, 95% confidence interval (CI) 0.13 to 2.85; 3 studies, 286 participants; very low‐certainty evidence). UF may have little to no effect on all‐cause mortality at the longest available follow‐up (RR 1.00, 95% CI 0.73 to 1.36; 9 studies, 987 participants; low‐certainty evidence). </p> <p>UF may reduce all‐cause rehospitalisation at 30 days or less (RR 0.76, 95% CI 0.53 to 1.09; 3 studies, 337 participants; low‐certainty evidence). UF may slightly reduce all‐cause rehospitalisation at longest available follow‐up (RR 0.91, 95% CI 0.79 to 1.05; 6 studies, 612 participants; low‐certainty evidence). </p> <p>UF may reduce heart failure‐related rehospitalisation at 30 days or less (RR 0.62, 95% CI 0.37 to 1.04; 2 studies, 395 participants; low‐certainty evidence). UF probably reduces heart failure‐related rehospitalisation at longest available follow‐up, with a number needed to treat for an additional beneficial effect (NNTB) of 10 (RR 0.69, 95% CI 0.53 to 0.90; 4 studies, 636 participants; moderate‐certainty evidence).  </p> <p>No studies measured need for mechanical ventilation. </p> <p>UF may have little or no effect on serum creatinine change at 30 days since discharge (mean difference (MD) 14%, 95% CI −12% to 40%; 1 study, 221 participants; low‐certainty evidence). UF may increase the risk of new initiation of renal replacement therapy at longest available follow‐up (RR 1.42, 95% CI 0.42 to 4.75; 4 studies, 332 participants; low‐certainty evidence).  </p> <p>There is an uncertain effect of UF on the risk of complications from central line insertion in hospital (RR 4.16, 95% CI 1.30 to 13.30; 6 studies, 779 participants; very low‐certainty evidence).  </p> </section> <section id="CD013593-sec-0007"> <h3 class="title" id="CD013593-sec-0007">Authors' conclusions</h3> <p>This review summarises the latest evidence on UF in AHF. Moderate‐certainty evidence shows UF probably reduces heart failure‐related rehospitalisation in the long term, with an NNTB of 10. UF may reduce all‐cause rehospitalisation at 30 days or less and at longest available follow‐up. The effect of UF on all‐cause mortality at 30 days or less is unclear, and it may have little effect on all‐cause mortality in the long‐term.  </p> <p>While UF may have little or no effect on serum creatinine change at 30 days, it may increase the risk of new initiation of renal replacement therapy in the long term. The effect on complications from central line insertion is unclear.  </p> <p>There is insufficient evidence to determine the true impact of UF on AHF. Future research should evaluate UF as an adjunct therapy, focusing on outcomes such as heart failure‐related rehospitalisation, cardiac mortality and renal outcomes at medium‐ to long‐term follow‐up.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013593-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013593-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013593-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013593-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013593-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013593-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013593-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013593-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013593-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013593-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013593-abs-0002" lang="en"> <h3>Fluid removal therapy in acute heart failure</h3> <p><b>Review question</b> </p> <p>What are the effects of ultrafiltration (UF), a fluid removal therapy, in acute heart failure (AHF)? </p> <p><b>Background</b> </p> <p>AHF is a common condition where the heart does not pump effectively, causing fluid to accumulate in the lungs and body. This causes difficulty in breathing, damage to heart and kidneys, high readmission to hospital and high death rates. Usual care involves medications called diuretics to remove this excess fluid, but some people may become resistant to it. UF provides an alternative therapy to quickly remove fluid. A circuit removes blood from the patient, which is then filtered in a machine before going back to the patient. It requires monitoring, a large central line cannula (tube into a blood vessel) and a blood thinning medication. It is unclear whether UF is effective or safe in AHF.   </p> <p><b>Study characteristics</b> </p> <p>We searched for studies comparing UF to usual care in people with AHF. We searched for all relevant studies up to June 2021 and found 14 studies with about 1200 people. People who were very sick and frail, such as those who have had heart attacks and infections, were often not studied. </p> <p><b>Certainty of the evidence</b> </p> <p>We used a validated tool (GRADE) to assess how certain we were of our results. Overall, there was low‐certainty evidence from these studies because of variability in the study settings, conflicting results between studies and limitations in how the studies were designed.  </p> <p><b>Key results</b> </p> <p>We are uncertain whether UF has an impact on death rates at a short‐term follow‐up, as there are not enough data. At the longest time of follow‐up, UF may have little effect on death rates.  </p> <p>UF may reduce readmission to hospital rates within the short and long term. In particular, readmission rates from heart failure are probably reduced by 31% when followed up over a longer time frame (up to one year). The benefit of reducing heart failure‐related rehospitalisation is seen in 1 of 10 people treated with UF. </p> <p>UF may increase the risk of needing long‐term dialysis. It is not clear whether UF affects kidney function at 30 days since hospital discharge, or if the risk of central line complications are greater with UF. No studies researched the effect of UF on needing mechanical breathing support, or its effect on cost and health economics.  </p> <p>More robust studies looking at UF in conjunction with current therapy are needed. These should focus on outcomes that are important to patients, such as heart failure‐related hospital readmission rates, cardiac death rates and kidney damage at medium to long term.  </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013593-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013593-sec-0067"></div> <h3 class="title" id="CD013593-sec-0068">Implications for practice</h3> <section id="CD013593-sec-0068"> <p>The primary implication for practice is that ultrafiltration (UF) probably reduces heart failure (HF)‐related rehospitalisation at the longest available follow‐up. Moderate‐certainty evidence from four randomised controlled trials (RCTs) suggest a large and clinically significant estimated effect size (number need to treat for an additional beneficial outcome = 10). UF may reduce all‐cause rehospitalisation in the short and long term, while the effect on all‐cause mortality is unclear at 30days or less, and may have little effect in the long term.   </p> <p>Given that HF‐related rehospitalisation is a major public health burden, this finding could suggest a role for UF in people with acute heart failure (AHF) similar to those enrolled in the included RCTs. RCTs were conducted in middle‐ to high‐income countries, including people with AHF with hypervolaemia who were not critically unwell. In this patient population, readmission due to inadequate decongestion is a common and ongoing problem, which would be expected to impose a quality of life burden on affected patients.   </p> <p>This has to be balanced with the risk of complications, since UF may increase the risk of initiating long‐term dialysis. The risk from central venous access in UF is uncertain, but should be considered by physicians and patients to engage in shared decision‐making regarding the initiation of UF. Since UF can be achieved through different types of venous access that are less invasive, this would be a point of consideration.  </p> <p>No prospective cost analysis of UF has been conducted. From a health economics and policy perspective, decision makers will have to weigh up healthcare utilisation costs of UF against potential benefits such as reduction in HF‐related rehospitalisations.   </p> <p>Overall, no strong recommendation for UF can be made at this time based on the uncertainty of the evidence presented, but in carefully selected cases it may be appropriate. </p> </section> <h3 class="title" id="CD013593-sec-0069">Implications for research</h3> <section id="CD013593-sec-0069"> <p>The certainty of the evidence for UF is significantly limited by the choice of endpoints in our included trials. For instance, while creatinine changes and weight changes are reported in nearly all studies, there was less consistent reporting of more patient‐centred outcomes such as HF‐related rehospitalisation, mortality, hospital length of stay and need for renal replacement therapy. There are a few likely reasons for this.  </p> <p>First, weight change and change in serum creatinine are relatively easier to measure as trial endpoints than clinical outcomes such as HF‐related mortality, rehospitalisation and others that require extended follow‐up in a rigorous manner outside the hospital. Such clinical outcomes were measured in the few large RCTs but generally absent from the smaller studies.  While there appears to be pragmatic barriers to further large RCTs with follow‐up of clinically meaningful outcomes, such studies are nevertheless needed. </p> <p>Second, certain paradigms in the understanding of AHF have changed over time. Previous studies chose serum creatinine at short follow‐up as an endpoint, which is now understood to not be a clinically significant outcome or a meaningful measure of adverse events. Many studies did not evaluate need for renal replacement therapy, an important patient‐centred outcome. Cardiac and HF‐specific outcomes were poorly studied, which may underestimate the true clinical effect of UF given it is not expected to alter the disease course but rather help with decongestion. This is relevant to the endpoints and duration of follow‐up in future clinical trials.  </p> <p>Last, UF is targeted as a complementary therapy to usual care to help improve diuretic responsiveness, rather than as an alternative option. Future studies should focus on this, as this will provide data that translate well into clinical practice.   </p> <p>Thus, changing understanding of AHF has potentially moved the goal posts for what an ideal primary trial endpoint should be when comparing UF to usual care.  Future studies should focus on clinical outcomes such as HF‐related rehospitalisation, cardiac mortality and renal outcomes at medium‐ to long‐term follow‐up. Studies should evaluate the benefit of UF as a complementary therapy, and further research of critically unwell patients may also be additive. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013593-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013593-sec-0008"></div> <div class="table" id="CD013593-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Patient or population:</b> people with AHF </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> UF </p> <p><b>Comparison:</b> UC </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with UC</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with UF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(3 to 56) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.61</b><br/>(0.13 to 2.85) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain about the effects of UF on all‐cause mortality, up to and including 30 days from discharge. </p> <p>Baseline risk (assumed control risk) for death in people with AHF within 30 days of admission taken from <a href="./references#CD013593-bbs2-0081" title="Miró Ò, RosselloX , GilV , Martín-SánchezFJ , LlorensP , Herrero-PuenteP , et al.Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Annals of Internal Medicine2017;167(10):698-705.">Miró 2017</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>124 per 1000</b> </p> <p>(91 to 169)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> </p> <p>(0.73 to 1.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>987</p> <p>(9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯ <b>Low</b><sup>b,c</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may have little to no effect on all‐cause mortality at longest available follow‐up, but the CI also includes appreciable benefit or harm. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause rehospitalisation</b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>221 per 1000</b><br/>(154 to 317) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b><br/>(0.53 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>337<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may reduce all‐cause rehospitalisation up to 30 days from discharge.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>531 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>484 per 1000</b> </p> <p>(420 to 558)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> </p> <p>(0.79 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>612</p> <p>(6 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> <p>⨁⨁◯◯ <b>Low</b><sup>b,c</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may slightly reduce all‐cause rehospitalisation at longest available follow‐up.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Heart failure‐related rehospitalisation </b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b><br/>(67 to 184) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.62</b><br/>(0.37 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>395<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may reduce heart failure‐related rehospitalisation up to and including 30 days from discharge. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>229 per 1000</b> </p> <p>(176 to 298)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.69</b> </p> <p>(0.53 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯ <b>Moderate</b><sup>b</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF probably reduces heart failure‐related rehospitalisation at longest available follow‐up. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Need for mechanical invasive ventilation</b> –<b> </b>up to and including 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>0 studies reported the need for mechanical ventilation, at any time point, for the comparison of UF vs UC. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>% Change in serum creatinine</b> –<b> </b> at 30 days from<b> </b>discharge </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in serum creatinine with UF at 30 days from discharge was 25% </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 14% higher</b> </p> <p>(12% lower to 40% higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>221<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may have little or no difference on serum creatinine change at 30 days from discharge. &gt; 30% serum creatinine change is clinically meaningful <a href="./references#CD013593-bbs2-0090" title="SchmidtM , MansfieldKE , BhaskaranK , NitschD , SørensenHT , SmeethL , et al.Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ (Clinical Research Ed.)2017;356:j791.">Schmidt 2017</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>New initiation of renal replacement therapy</b> –<b> </b>at longest available follow‐up </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/>(10 to 114) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.42</b><br/>(0.42 to 4.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>322<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may increase the risk of new initiation of renal replacement therapy. </p> <p>1 additional study reported 0 events in both arms (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>: UF = 0/15, UC = 0/15). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Complications of central line insertion</b> – in hospital </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/>(13 to 49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.16</b><br/>(1.30 to 13.30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>779<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is an uncertain effect of UF on complications from central line insertion.</p> <p>2 additional studies reported 0 events in both arms (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>: UF = 0/15; UC = 0/15 and <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>: UF = 0/27; UC = 0/29). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b>  (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHF:</b> acute heart failure; <b>CI:</b>  confidence interval; <b>MD:</b>  mean difference; <b>RCT:</b> randomised control trial; <b>RR:</b>  risk ratio; <b>UC:</b> usual care; <b>UF:</b> ultrafiltration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b>  we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b>  we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b>  our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Small sample size and low event rate, CI included no effect and also included default values for appreciable harm (CI &gt; 1.25) or appreciable benefit (CI &lt; 0.75), or both; therefore, certainty of evidence downgraded two levels for imprecision.<br/><sup>b</sup>Proportion of information from studies at high risk of bias was sufficient to lower confidence in the estimate of effect; therefore, certainty of evidence downgraded one level for methodological limitations.<br/><sup>c</sup>CI included no effect and also included default values for appreciable harm (CI &gt; 1.25) or appreciable benefit (CI &lt; 0.75), or both; therefore, certainty of evidence downgraded one level for imprecision.<br/><sup>d</sup>Small sample size and CI included no effect; therefore, certainty of evidence downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013593-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013593-sec-0009"></div> <section id="CD013593-sec-0010"> <h3 class="title" id="CD013593-sec-0010">Description of the condition</h3> <p>Heart failure (HF) is a clinical syndrome caused by any structural or functional (or both) impairment in the ability of the heart to fill or eject blood (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>; <a href="./references#CD013593-bbs2-0100" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDE , DraznerMH , et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary. Circulation2013;128(16):1810-52.">Yancy 2013</a>). This leads to reduced cardiac output or increased intracardiac pressures, or both, resulting in symptoms such as dyspnoea, fatigue and peripheral oedema. Acute heart failure (AHF) is any rapid deterioration of HF signs and symptoms requiring urgent therapy (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>; <a href="./references#CD013593-bbs2-0100" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDE , DraznerMH , et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary. Circulation2013;128(16):1810-52.">Yancy 2013</a>). AHF can be precipitated by a variety of factors, such as ischaemia, arrhythmia, non‐adherence to diet or medications, pneumonia/respiratory processes, hypertension and worsening renal function (<a href="./references#CD013593-bbs2-0063" title="FonarowGC , AbrahamWT , AlbertNM , StoughWG , GheorghiadeM , GreenbergBH , et al.Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. INTEMED2008;168(8):847-54.">Fonarow 2008</a>). Numerous prognostic factors for AHF have been previously described (<a href="./references#CD013593-bbs2-0069" title="HollenbergSM , WarnerSL , AhmadT , AminVJ , BozkurtB , ButlerJ , et al.2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology2019;74(15):1966-2011.">Hollenberg 2019</a>), among them advanced age and decreased kidney function (estimated glomerular filtration rate (eGFR) less than 60 mL/minute) (<a href="./references#CD013593-bbs2-0069" title="HollenbergSM , WarnerSL , AhmadT , AminVJ , BozkurtB , ButlerJ , et al.2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology2019;74(15):1966-2011.">Hollenberg 2019</a>; <a href="./references#CD013593-bbs2-0087" title="RangaswamiJ , BhallaV , BlairJE , ChangTI , CostaS , LentineKL , et al.Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation2019;139(16):e840-78.">Rangaswami 2019</a>).  </p> <p>AHF is a heterogeneous set of clinical syndromes, with several classification systems in place (<a href="./references#CD013593-bbs2-0045" title="AllaF , ZannadF , FilippatosG .Epidemiology of acute heart failure syndromes. Heart Failure Reviews2007;12(2):91-5.">Alla 2007</a>). It can be divided into people with existing, chronic HF with an acute decompensation (65% to 75% of patients hospitalised), or first presentation de novo HF (<a href="./references#CD013593-bbs2-0060" title="FarmakisD , ParissisJ , PapingiotisG ,  Filippatos G.Acute heart failure: epidemiology, classification, and pathophysiology. In: Tubaro M, Vranckx P, PriceS , Vrints C, editors(s). The ESC Textbook of Intensive and Acute Cardiovascular Care. 2nd edition. Oxford (UK): Oxford University Press, 2018.">Farmakis 2018</a>; <a href="./references#CD013593-bbs2-0064" title="GheorghiadeM , ZannadF , SopkoG , KleinL , PiñaIL , KonstamMA , et al.Acute heart failure syndromes. Circulation2005;112(25):3958-68.">Gheorghiade 2005</a>; <a href="./references#CD013593-bbs2-0083" title="NieminenMS , BrutsaertD , DicksteinK , DrexlerH , FollathF , HarjolaVP , et al.EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. European Heart Journal2006;27(22):2725-36.">Nieminen 2006</a>). Patients can be classified according to left ventricular ejection fraction (LVEF), as HF with reduced LVEF less than 40% (HFrEF), mid‐range LVEF 40% to 49% (HFmrEF), or HF with preserved LVEF of 50% or greater (HFpEF) (<a href="./references#CD013593-bbs2-0060" title="FarmakisD , ParissisJ , PapingiotisG ,  Filippatos G.Acute heart failure: epidemiology, classification, and pathophysiology. In: Tubaro M, Vranckx P, PriceS , Vrints C, editors(s). The ESC Textbook of Intensive and Acute Cardiovascular Care. 2nd edition. Oxford (UK): Oxford University Press, 2018.">Farmakis 2018</a>). Another useful way of classifying AHF is through clinical profiles, looking at the presence or absence of hypoperfusion (cold peripheries, oliguria, dizziness, altered mental state) or congestion (pulmonary congestion, orthopnoea, peripheral oedema, ascites) (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>; <a href="./references#CD013593-bbs2-0100" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDE , DraznerMH , et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary. Circulation2013;128(16):1810-52.">Yancy 2013</a>). This can guide initial treatment as well as provide prognostic information.  </p> <p>Treatment goals in AHF include improvement in symptoms, limiting cardiac and renal injury, and preventing early readmission. Reducing congestion is a key goal in AHF, given that most people present with these symptoms (<a href="./references#CD013593-bbs2-0046" title="AmbrosyAP , Fonarow GC, ButlerJ , ChioncelO , GreeneSJ , VaduganathanM , et al.The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. Journal of the American College of Cardiology2014;63(12):1123-33.">Ambrosy 2014</a>). Pharmacotherapies such as loop diuretics are the primary treatments, administered to over 90% of patients (<a href="./references#CD013593-bbs2-0062" title="FonarowGC , HeywoodJT , HeidenreichPA , LopatinM , YancyCW , ADHERE Scientific Advisory Committee and Investigators.Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal2007;153(6):1021-8.">Fonarow 2007</a>; <a href="./references#CD013593-bbs2-0076" title="LlorensP , EscodaR , Miró Ò, Herrero-PuenteP , Martín-SánchezFJ , JacobJ , et al.Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments). Emergencias: Revista de la Sociedad Espanola de Medicina de Emergencias2015;27(1):11-22.">Llorens 2015</a>). They reduce sodium re‐absorption, which in turn increases water excretion and hypotonic urine production (<a href="./references#CD013593-bbs2-0051" title="CasuG , MerellaP .Diuretic therapy in heart failure – current approaches. European Cardiology2015;10(1):42-7.">Casu 2015</a>). Dosage is adjusted according to the individual's clinical status, which is monitored by evaluating the patient's signs and symptoms, such as reduction in dyspnoea or daily weight. In some patients, there is poor response to pharmacotherapy, or diuretic resistance develops (<a href="./references#CD013593-bbs2-0061" title="FelkerM .Diuretic management in heart failure. Congestive Heart Failure (Greenwich, Conn.)2010;16(Suppl 1):S68-72.">Felker 2010</a>; <a href="./references#CD013593-bbs2-0096" title="ter MaatenJM , ValenteMA , DammanK , HillegeHL , NavisG , VoorsAA .Diuretic response in acute heart failure – pathophysiology, evaluation, and therapy. Nature Reviews in Cardiology2015;12(3):184-92.">ter Maaten 2015</a>), leading to refractory central venous congestion. Despite their common use, diuretics do not reduce mortality, and are associated with neuro‐hormonal activation, worsening renal function, electrolyte abnormalities and arrhythmias (<a href="./references#CD013593-bbs2-0084" title="PalazzuoliA , RuoccoG , VescovoG , ValleR , Di SommaS , NutiR .Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF. ESC Heart Failure2017;4(4):479-86.">Palazzuoli 2017</a>). </p> <p>Shortness of breath is rated as the most‐bothersome symptom in about 50% to 60% of people with AHF, compared to 29% reporting oedema as their most bothersome symptom (<a href="http://Omar 2016" target="_blank">Omar 2016</a>). In people with acute pulmonary oedema, non‐invasive ventilation to provide positive pressure has become more common since the early 2000's (<a href="./references#CD013593-bbs2-0079" title="MasipJ , PeacockWF , PriceS , CullenL , Martin-SanchezFJ , SeferovicP , et al.Indications and practical approach to non-invasive ventilation in acute heart failure. European Heart Journal2018;39(1):17-25.">Masip 2018</a>). This has reduced risk of pneumonia compared to traditional endotracheal intubation (<a href="./references#CD013593-bbs2-0050" title="CarronM , FreoU , BaHammamAS , DellwegD , GuarracinoF , CosentiniR , et al.Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. British Journal of Anaesthesia2013;110(6):896-914.">Carron 2013</a>). However, in people with persisting respiratory failure, mechanical invasive ventilation may still be needed (<a href="./references#CD013593-bbs2-0079" title="MasipJ , PeacockWF , PriceS , CullenL , Martin-SanchezFJ , SeferovicP , et al.Indications and practical approach to non-invasive ventilation in acute heart failure. European Heart Journal2018;39(1):17-25.">Masip 2018</a>).  </p> </section> <section id="CD013593-sec-0011"> <h3 class="title" id="CD013593-sec-0011">Description of the intervention</h3> <p>Ultrafiltration (UF) is the removal of isotonic plasma fluid from whole blood across a semipermeable membrane (haemofilter) in response to a transmembrane pressure gradient (<a href="./references#CD013593-bbs2-0089" title="RoncoC , HaapioM , HouseAA , AnavekarN , BellomoR .Cardiorenal syndrome. Journal of the American College of Cardiology2008;52(19):1527.">Ronco 2008</a>). The UF circuit removes blood from the patient via a venous line (typically a central venous catheter). A syringe pump drives blood across the haemofilter within the extracorporeal circuit. Isotonic plasma fluid is removed here from the blood down the pressure gradient, after which the blood is returned to the patient (<a href="./references#CD013593-bbs2-0056" title="CostanzoMR .Ultrafiltration in acute heart failure. Cardiac Failure Review2019;5(1):9-18.">Costanzo 2019a</a>). Portable UF devices are now available that do not require high‐level care monitoring, and the rate and volume of fluid removal can be precisely controlled. Anticoagulation is needed for patients to prevent filter clotting (<a href="./references#CD013593-bbs2-0056" title="CostanzoMR .Ultrafiltration in acute heart failure. Cardiac Failure Review2019;5(1):9-18.">Costanzo 2019a</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>). </p> </section> <section id="CD013593-sec-0012"> <h3 class="title" id="CD013593-sec-0012">How the intervention might work</h3> <p>UF allows for effective and rapid decongestion. By removing isotonic plasma fluid, greater concentration of sodium per volume can be extracted, compared to diuretic use where hypotonic urine is excreted. This fluid removal can occur in a precise manner by controlling the rate and volume. It is associated with a reduction of intracardiac pressures (right atrial and pulmonary wedge pressures), as well as increased cardiac output (<a href="./references#CD013593-bbs2-0065" title="GiglioliC , LandiD , GensiniGF , ValenteS , CecchiE , ScollettaS , et al.Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report. Blood Purification2010;29(1):44-51.">Giglioli 2010</a>; <a href="./references#CD013593-bbs2-0078" title="MarenziGC , LauriG , GraziM , AssanelliE , CampodonicoJ , AgostoniPG .Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. Journal of the American College of Cardiology2001;38(4):963-8.">Marenzi 2001</a>). It also reduces renal venous congestion and improves renal haemodynamics and response to diuretic therapy (<a href="./references#CD013593-bbs2-0056" title="CostanzoMR .Ultrafiltration in acute heart failure. Cardiac Failure Review2019;5(1):9-18.">Costanzo 2019a</a>; <a href="./references#CD013593-bbs2-0065" title="GiglioliC , LandiD , GensiniGF , ValenteS , CecchiE , ScollettaS , et al.Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report. Blood Purification2010;29(1):44-51.">Giglioli 2010</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>).  </p> <p>We expect the intervention to impact short‐ and medium‐term outcomes rather than alter the HF disease course. There is some limited evidence of sustained beneficial effects months after UF use (<a href="./references#CD013593-bbs2-0042" title="AgostoniP ,  MarenziG ,  LauriG ,  PeregoG ,  SchianniM ,  SganzerlaP , et al.Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. American Journal of Medicine1994;96(3):191-9.">Agostoni 1994</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>), which may be due to reduced neurohormonal activation, improved renal haemodynamics or other theoretically beneficial physiological effects (<a href="./references#CD013593-bbs2-0068" title="HartupeeJ , MannDL .Neurohormonal activation in heart failure with reduced ejection fraction. Nature Reviews. Cardiology2017;14(1):30-8.">Hartupee 2017</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>; <a href="./references#CD013593-bbs2-0087" title="RangaswamiJ , BhallaV , BlairJE , ChangTI , CostaS , LentineKL , et al.Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation2019;139(16):e840-78.">Rangaswami 2019</a>). </p> </section> <section id="CD013593-sec-0013"> <h3 class="title" id="CD013593-sec-0013">Why it is important to do this review</h3> <p>AHF is widely prevalent across the globe and is associated with high mortality and morbidity. In‐hospital mortality rates range from 4% in US to 7% in European surveys (<a href="./references#CD013593-bbs2-0060" title="FarmakisD , ParissisJ , PapingiotisG ,  Filippatos G.Acute heart failure: epidemiology, classification, and pathophysiology. In: Tubaro M, Vranckx P, PriceS , Vrints C, editors(s). The ESC Textbook of Intensive and Acute Cardiovascular Care. 2nd edition. Oxford (UK): Oxford University Press, 2018.">Farmakis 2018</a>). It is also the leading cause of hospitalisation in individuals over the age of 65 years in high‐income countries, representing 1% to 2% of all admissions (<a href="./references#CD013593-bbs2-0064" title="GheorghiadeM , ZannadF , SopkoG , KleinL , PiñaIL , KonstamMA , et al.Acute heart failure syndromes. Circulation2005;112(25):3958-68.">Gheorghiade 2005</a>; <a href="./references#CD013593-bbs2-0095" title="StorrowAB , JenkinsCA , SelfWH , AlexanderPT , BarrettTW , HanJH , et al.The burden of acute heart failure on U.S. emergency departments. JACC. Heart Failure2014;2(3):269-77.">Storrow 2014</a>). In the USA, HF results in one million emergency department presentations and accounts for 1% to 2% of healthcare resource utilisation, 75% of which is attributed to hospitalisations (<a href="./references#CD013593-bbs2-0049" title="BundkirchenA , SchwingerRH .Epidemiology and economic burden of chronic heart failure. European Heart Journal2004;6(Suppl D):D57-60.">Bundkirchen 2004</a>). High rates of rehospitalisation are seen with AHF, with rates ranging from 22% to 30% at one to three months (<a href="./references#CD013593-bbs2-0060" title="FarmakisD , ParissisJ , PapingiotisG ,  Filippatos G.Acute heart failure: epidemiology, classification, and pathophysiology. In: Tubaro M, Vranckx P, PriceS , Vrints C, editors(s). The ESC Textbook of Intensive and Acute Cardiovascular Care. 2nd edition. Oxford (UK): Oxford University Press, 2018.">Farmakis 2018</a>). </p> <p>Despite the high prevalence and burden of disease, there have been limited advances in AHF therapy in recent years (<a href="./references#CD013593-bbs2-0044" title="AlexanderP , AlkhawamL , CurryJ , LevyP , PangPS , StorrowAB , et al.Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review. American Journal of Emergency Medicine2015;33(2):133-41.">Alexander 2015</a>; <a href="./references#CD013593-bbs2-0054" title="CollinsS , StorrowAB , AlbertNM , ButlerJ , EzekowitzJ , FelkerGM , et al.Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the Society for Academic Emergency Medicine/Heart Failure Society of America Acute Heart Failure Working Group. Journal of Cardiac Failure2015;21(1):27-43.">Collins 2015</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>; <a href="./references#CD013593-bbs2-0077" title="MaG , MaX , WangG , TengW , HuiX .Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials. BMJ Open2019;9(4):e025537.">Ma 2019</a>; <a href="./references#CD013593-bbs2-0080" title="MetraM , TeerlinkJR , CotterG , DavisonBA , FelkerGM , FilippatosG , et al.Effects of serelaxin in patients with acute heart failure. New England Journal of Medicine2019;381(8):716-26.">Metra 2019</a>; <a href="./references#CD013593-bbs2-0097" title="WangC , XiongB , CaiL .Effects of tolvaptan in patients with acute heart failure: a systematic review and meta-analysis. BMC Cardiovascular Disorders2017;17(1):164.">Wang 2017</a>). UF has physiological and theoretical clinical appeal, however its risks and benefits over the current standard of care must be evaluated. </p> <p>The most significant adverse effect of UF is acute kidney injury. Removal of fluid via UF can cause significant haemodynamic shifts and therefore temporary renal hypoperfusion (<a href="./references#CD013593-bbs2-0098" title="WehbeE , PatarroyoM , TaliercioJJ , StarlingRC , Nally JV Jr, TangWH , et al.Renal failure requiring dialysis complicating slow continuous ultrafiltration in acute heart failure: importance of systolic perfusion pressure. Journal of Cardiac Failure2015;21(2):108-15.">Wehbe 2015</a>). However, it is now recognised that transient rise in serum creatinine during AHF therapy is not necessarily indicative of acute kidney injury (<a href="./references#CD013593-bbs2-0043" title="AhmadT , JacksonK , RaoVS , TangWH , Brisco-BacikMA , ChenHH , et al.Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation2018;137(19):2016-8.">Ahmad 2018</a>), and may not be a meaningful marker of long‐term adverse outcomes (<a href="./references#CD013593-bbs2-0053" title="CocaSG , ZabetianA , FerketBS , ZhouJ , TestaniJM , GargAX , et al.Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials. Journal of the American Society of Nephrology : JASN2016;27(8):2529-42.">Coca 2016</a>). Long‐term renal effects of UF are unclear, with retrospective and observational UF studies suggesting a risk of renal replacement therapy with dialysis (<a href="./references#CD013593-bbs2-0074" title="LiangKV , HinikerAR , WilliamsAW , KaronBL , GreeneEL , RedfieldMM .Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. Journal of Cardiac Failure2006;12(9):707-14.">Liang 2006</a>; <a href="./references#CD013593-bbs2-0085" title="PatarroyoM , WehbeE , HannaM , TaylorDO , StarlingRC , DemirjianS , et al.Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. Journal of the American College of Cardiology2012;60(19):1906-12.">Patarroyo 2012</a>), while some randomised trials with shorter follow‐up have varied outcomes (<a href="./references#CD013593-bbs2-0055" title="CostanzoMR , RoncoC , AbrahamWT , AgostoniP , BaraschJ , FonarowGC , et al.Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research. Journal of the American College of Cardiology2017;69(19):2428-45.">Costanzo 2017</a>). </p> <p>Other risks are associated with catheter access including infection and flow problems, extracorporeal circuit clotting, bleeding due to over anticoagulation and hypotension due to intravascular depletion, which may require vasopressor support (<a href="./references#CD013593-bbs2-0055" title="CostanzoMR , RoncoC , AbrahamWT , AgostoniP , BaraschJ , FonarowGC , et al.Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research. Journal of the American College of Cardiology2017;69(19):2428-45.">Costanzo 2017</a>; <a href="./references#CD013593-bbs2-0074" title="LiangKV , HinikerAR , WilliamsAW , KaronBL , GreeneEL , RedfieldMM .Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. Journal of Cardiac Failure2006;12(9):707-14.">Liang 2006</a>). These risks have been inconsistently reported in previous studies (<a href="./references#CD013593-bbs2-0092" title="ShiX , BaoJ , ZhangH , WangH , LiL , ZhangY .Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews2019;24(6):927.">Shi 2019</a>). </p> <p>The economic implications also need to be considered since UF devices are expensive with increased healthcare staff and resource utilisation (<a href="./references#CD013593-bbs2-0056" title="CostanzoMR .Ultrafiltration in acute heart failure. Cardiac Failure Review2019;5(1):9-18.">Costanzo 2019a</a>; <a href="./references#CD013593-bbs2-0071" title="KazoryA .Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clinical Journal of the American Society of Nephrology: CJASN2016;11(8):1463-71.">Kazory 2016</a>). No prospective cost analysis of UF is available (<a href="./references#CD013593-bbs2-0055" title="CostanzoMR , RoncoC , AbrahamWT , AgostoniP , BaraschJ , FonarowGC , et al.Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research. Journal of the American College of Cardiology2017;69(19):2428-45.">Costanzo 2017</a>), and the limited retrospective analysis is inconclusive and conflicting. One analysis suggests that UF is unlikely to reduce cost from a societal perspective (<a href="./references#CD013593-bbs2-0048" title="BradleySM , LevyWC , VeenstraDL .Cost-consequences of ultrafiltration for acute heart failure. Circulation: Cardiovascular Quality and Outcomes2009;2(6):566-73.">Bradley 2009</a>), with another suggesting that despite the higher up‐front costs, UF reduces longer‐term costs through reduction in rehospitalisation rates (<a href="./references#CD013593-bbs2-0057" title="CostanzoMR , FonarowGC , RizzoJA .Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis. Journal of Medical Economics2019;22(6):577-83.">Costanzo 2019b</a>). </p> <p>Current international guidelines advise that UF therapy may benefit people with diuretic resistance, but the quality of the evidence is low. The 2016 European Society of Cardiology guidelines recommend that UF may be considered for people with refractory congestion who fail to respond to diuretic‐based strategies (quality of evidence – class IIb, level B) (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>). The 2013 American College of Cardiology/American Heart Association guidelines suggest that UF may be considered in people with obvious volume overload (class IIb, level B) or refractory congestion (class IIb, level C) (<a href="./references#CD013593-bbs2-0100" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDE , DraznerMH , et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary. Circulation2013;128(16):1810-52.">Yancy 2013</a>). A key research recommendation from the 2014 National Clinical Guideline Centre is evaluating whether UF can provide more rapid and effective decongestion compared to diuretics (<a href="./references#CD013593-bbs2-0082" title="National Clinical Guideline Centre.Acute heart failure: diagnosing and managing acute heart failure in adults. National Institute for Health and Care Excellence (NICE): Clinical Guideline 187. www.nice.org.uk/guidance/cg187.">NICE 2014</a>). </p> <p>This Cochrane Review aims to provide stronger‐quality evidence by comparing UF to usual care (UC) with diuretic therapy. It summarises the current evidence, evaluating the effect of UF on mortality, rehospitalisation rates and adverse renal outcomes. This can help guide clinical practice as well as identify gaps in current research. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013593-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013593-sec-0014"></div> <section id="CD013593-sec-0015"> <h3 class="title" id="CD013593-sec-0015">Primary objective</h3> <p> <ul id="CD013593-list-0001"> <li> <p>To assess the effects of UF compared to diuretic therapy alone on clinical outcomes such as mortality and rehospitalisation rates. </p> </li> </ul> </p> </section> <section id="CD013593-sec-0016"> <h3 class="title" id="CD013593-sec-0016">Secondary objectives</h3> <p> <ul id="CD013593-list-0002"> <li> <p>To assess whether the effects of UF differ in people with existing HF (HFrEF, HFmrEF or HFpEF). </p> </li> <li> <p>To assess whether the effects of UF differ in people with or without renal impairment at the time of admission (eGFR less than 60 mL/minute). </p> </li> <li> <p>To assess whether the effects of UF differ in settings with early initiation of UF therapy (less than 24 hours since admission) compared to delayed initiation in refractory congestion. </p> </li> <li> <p>To assess whether the effects of UF differ in UF with intravenous diuretics versus UF alone. </p> </li> </ul> </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013593-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013593-sec-0017"></div> <section id="CD013593-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013593-sec-0019"> <h4 class="title">Types of studies</h4> <p>We included parallel‐arm randomised controlled trials (RCTs). We excluded cross‐over RCTs given the acute nature of the illness. The search found no cluster RCTs. We included studies reported as full text, those published as abstract only, and unpublished data. </p> </section> <section id="CD013593-sec-0020"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years or over) with a clinical diagnosis of AHF of any severity or due to any aetiology, as defined by the investigators. We excluded participants with pre‐existing dialysis dependence.  </p> <p>In trials with mixed populations, that is trials where some participants met the inclusion criteria and others did not, we attempted to include only the eligible participants if this information was reported separately or could be obtained from the trial authors. Otherwise, we included studies with a mixed population if the majority (greater than 50%) of participants meet the eligibility criteria. </p> </section> <section id="CD013593-sec-0021"> <h4 class="title">Types of interventions</h4> <p>We included trials where the intervention was UF compared to UC (defined as any intervention strategy not including UF). There were no restrictions on the duration, dosage or administration of diuretic use. We included UF through extracorporeal circuits. </p> </section> <section id="CD013593-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>Reporting one or more of the outcomes listed here in the trial was not an inclusion criterion for the review. Where a published report had not reported one of these outcomes, we attempted to access the trial protocol and contact the trial authors to ascertain whether the outcomes were measured but not reported. We included relevant trials that measured these outcomes but did not report the data at all, or not in a usable format, in the review as part of the narrative. </p> <p>In studies where a time point was not specified, we attempted to contact the trial authors to obtain participant‐level data. If this was not available, we categorised it as longest available follow‐up. </p> <p>We collected data on tertiary outcomes such as quality of life and economic costs where this information was available, commenting on these outcomes narratively in the <a href="#CD013593-sec-0061">Discussion</a> section. </p> <section id="CD013593-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013593-list-0003"> <li> <p>All‐cause mortality – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>All‐cause rehospitalisation – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>HF‐related rehospitalisation – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> </ul> </p> </section> <section id="CD013593-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013593-list-0004"> <li> <p>Weight change at longest in‐hospital follow‐up.</p> </li> <li> <p>Need for mechanical invasive ventilation – up to and including 30 days from discharge.</p> </li> <li> <p>Hospital length of stay.</p> </li> <li> <p>Cardiac mortality – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>Change in serum creatinine (% change from admission) – 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>New initiation of long‐term renal replacement therapy at longest available follow‐up.</p> </li> <li> <p>Major bleeding (as defined by study authors), in‐hospital.</p> </li> <li> <p>Complications of central line insertion such as pneumothorax, bleeding, central line‐associated bloodstream infection (as defined by study authors), in‐hospital. </p> </li> </ul> </p> </section> </section> </section> <section id="CD013593-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013593-sec-0026"> <h4 class="title">Electronic searches</h4> <p>On 4 June 2021, we conducted a systematic search of the following bibliographic databases:</p> <p> <ul id="CD013593-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library (Issue 5, 2021); </p> </li> <li> <p>Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, MEDLINE Daily and MEDLINE (Ovid, 1946 to 3 June 2021); </p> </li> <li> <p>Embase (Ovid, 1980 to 2021 week 21);</p> </li> <li> <p>CPCI‐S (Conference Proceedings Citation Index‐Science) on the Web of Science (Clarivate Analytics, 1990 to 4 June 2021). </p> </li> </ul> </p> <p>We adapted the search strategy for MEDLINE (Ovid) (<a href="./appendices#CD013593-sec-0073">Appendix 1</a>) for use in the other databases. We applied the Cochrane sensitivity‐maximising RCT filter to MEDLINE (Ovid) and adaptations of it to the other databases, except CENTRAL (<a href="./references#CD013593-bbs2-0073" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al.Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from handbook: training.cochrane.org/handbook/archive/v6.">Lefebvre 2019</a>). We searched Web of Science CPCI‐S for relevant conference abstracts. </p> <p>We also searched for ongoing and unpublished trials through the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="https://www.trialsearch.who.int/Default.aspx" target="_blank">apps.who.int/trialsearch/</a>) in June 2021. </p> <p>We searched all databases from their inception and imposed no restrictions on language of publication or publication status. </p> </section> <section id="CD013593-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all included studies and any relevant systematic reviews identified for additional references to trials. We examined relevant retraction statements and errata for included studies. Where we needed participant‐level data for outcomes, we contacted authors to request missing data. </p> </section> </section> <section id="CD013593-sec-0028"> <h3 class="title" id="CD013593-sec-0028">Data collection and analysis</h3> <section id="CD013593-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MS, NH) independently screened titles and abstracts of all studies identified by the search for potential relevance, coding them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We resolved any disagreements by discussion. </p> <p>We retrieved the full‐text study reports, and two review authors (MS, NH) independently screened the full texts and identified studies for inclusion, and identified and recorded reasons for exclusion of the ineligible studies. We resolved any disagreements through discussion or by consulting a third review author (AFC) if necessary. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and <a href="./references#CD013593-sec-0083" title="">Characteristics of excluded studies</a> table (<a href="./references#CD013593-bbs2-0075" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GotzschePC , IoannidisJP , et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6(7):e1000100.">Liberati 2009</a>). </p> </section> <section id="CD013593-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form for study characteristics and outcome data that was piloted on one study in the review. Two review authors (MS, NH or author support AZ) extracted the following study characteristics from the included studies. </p> <p> <ul id="CD013593-list-0006"> <li> <p>Methods: study design, total duration of study, number of study centres and location, study setting and date of study. </p> </li> <li> <p>Participants: number randomised, number lost to follow‐up/withdrawn, number analysed, mean age, age range, gender (% women), ejection fraction classification (% HFpEF, HFmrEF, HFrEF), AHF diagnostic criteria used for enrolment, elevated cardiac troponin above/below the 99th percentile (%), chronic kidney disease stage (% I and II, % III and IV), creatinine and eGFR (mean), systolic blood pressure (mean, earliest reported value in hospital course), inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: intervention (UF type, UF duration in days, UF flow rate), comparison (loop diuretic type, loop diuretic % continuous versus bolus dosing, cumulative intravenous loop diuretic dose expressed in milligram furosemide equivalents), concomitant medications (i.e. loop diuretics used in UF group; adjunct diuretic medications in control group – metolazone, tolvaptan, acetazolamide, chlorothiazide) and excluded medications. </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial and notable conflicts of interest of trial authors.</p> </li> </ul> </p> <p>Two people independently extracted outcome data (review authors MS/NH with author support AZ), while author support AZ extracted characteristics of included studies.  </p> <p>We resolved any disagreements by consensus or by involving a third review author (AFC). One review author (AT) transferred data into Review Manager Web (<a href="./references#CD013593-bbs2-0088" title="The Cochrane CollaborationReview Manager Web (RevMan Web).Version accessed 22 April 2020. The Cochrane Collaboration, 2019. Available at revman.cochrane.org.">RevMan Web 2019</a>). We double‐checked that the data had been entered correctly by comparing the data presented in the systematic review with the data extraction form. A second review author (NH) spot‐checked study characteristics for accuracy against the trial report. </p> </section> <section id="CD013593-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MS/NH or ML/AFC) independently assessed risk of bias for each study using version 2 of the Cochrane risk of bias tool (RoB 2), outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013593-bbs2-0094" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:14898.">Sterne 2019</a>). We resolved any disagreements by discussion or by involving a third review author (AT) if needed. We assessed the risk of bias in the included studies according to domains of bias: </p> <p> <ul id="CD013593-list-0007"> <li> <p>arising from the randomisation process;</p> </li> <li> <p>due to deviations from intended interventions;</p> </li> <li> <p>due to missing outcome data;</p> </li> <li> <p>in measurement of the outcome and</p> </li> <li> <p>in selection of the reported result.</p> </li> </ul> </p> <p>We assessed the risk of bias for the outcomes of the included trials, which are included in <a href="./full#CD013593-tbl-0001">summary of findings Table 1</a>. We did ROB 2 assessments for all our primary outcomes at the time point of up to 30 days, as well as at the longest available follow‐up, even though this latter time point was not planned for the summary of findings table in the Cochrane Review protocol (<a href="./references#CD013593-bbs2-0101" title="SrivastavaM , HarrisonN , CaetanoAF , TanAR , LawM .Ultrafiltration for acute heart failure. Cochrane Database of Systematic Reviews2020, Issue 4. Art. No: CD013593. [DOI: 10.1002/14651858.CD013593]">Srivastava 2020</a>). This was done in discussion with content experts as this data might be clinically useful. We did additional ROB 2 assessments for weight change, to undertake sensitivity analysis given moderate heterogeneity. </p> <p>When conducting the risk of bias assessment, we quantified the effect of assignment to the interventions at baseline, regardless of whether the interventions were received as intended (the intention‐to‐treat effect). </p> <p>We used the signalling questions in the RoB 2 tool and rated each domain as 'low risk of bias', 'some concerns' or 'high risk of bias'. We summarised the risk of bias judgements across different studies for each of the domains listed for each outcome. The overall risk of bias for the result was the least favourable assessment across the domains of bias. </p> <p>When considering treatment effects, we considered the risk of bias for the studies that contributed to that outcome. </p> </section> <section id="CD013593-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risk ratios (RR) with 95% confidence intervals (CI) and continuous data as mean difference (MD) with 95% CIs. We entered data presented as a scale with a consistent direction of effect. </p> <p>We narratively described skewed data reported as medians and interquartile ranges.</p> <p>When an outcome event had the potential to occur more than once by a specified time point (e.g. rehospitalisation), we based analysis on the first event. </p> <p>When denominators differed between outcomes within a single study due to censoring, we used the denominators provided by the authors accounting for censoring. Censoring is a statistical concept that refers to the situation in which a patient could not experience a given outcome past a certain time (the time of censoring) because they were no longer in the study.  Examples of when censoring may occur include those in which a patient is lost to follow‐up (i.e. they left the study before the time point of interest for an outcome) or an event happened that precluded another outcome from occurring (e.g. a patient died at time X, so they could not experience rehospitalisation after time X and should not be included in the denominator).   </p> </section> <section id="CD013593-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant. In cases where a study reported that a participant received UF during more than one hospitalisation between enrolment and follow‐up, we contacted the authors to obtain individual participant data and calculated patient‐time at the unit of single hospitalisation with UF. </p> <p>If a study used more than two groups (specifically UF versus UF plus diuretic versus diuretic alone), we attempted to obtain participant‐level data from the study authors and analysed data as 'UF versus usual care'. To account for the potential bias introduced by grouping 'UF' with 'UF plus diuretic' groups (if a study was designed in such a way), we attempted to perform subgroup analysis as described in <a href="#CD013593-sec-0038">Subgroup analysis and investigation of heterogeneity</a>; however, insufficient studies reported this. </p> <p>Given that we are interested in multiple clinically relevant time points for certain primary and secondary outcomes (e.g. 30‐day versus longest available follow‐up), we first determined if a given study had reported outcomes in line with the time points of interest in our Cochrane Review protocol (<a href="./references#CD013593-bbs2-0101" title="SrivastavaM , HarrisonN , CaetanoAF , TanAR , LawM .Ultrafiltration for acute heart failure. Cochrane Database of Systematic Reviews2020, Issue 4. Art. No: CD013593. [DOI: 10.1002/14651858.CD013593]">Srivastava 2020</a>). If data were not primarily analysed in a given study for one or more time points of interest, we contacted the study authors for participant‐level data to be analysed at the time points in our Cochrane Review protocol. </p> <p>We did not anticipate other significant unit of analysis issues considering that we have excluded cross‐over, cluster, and before‐after designs. The intervention by its nature cannot be performed on multiple body parts. </p> </section> <section id="CD013593-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and to obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only). It was not possible to use the Review Manager Web calculator to calculate missing standard deviations (SDs) because additional data from the trial, such as CIs, MDs or P values necessary for methods outlined in <a href="./references#CD013593-bbs2-0094" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:14898.">Sterne 2019</a> were not available. Therefore, we imputed the SDs from one of the other studies and chose the highest value to be conservative, as this is likely to result in the widest CI (<a href="./references#CD013593-bbs2-0094" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:14898.">Sterne 2019</a>). We explored the impact of including studies with imputed SDs in the overall assessment of results by a sensitivity analysis including only studies without missing data. </p> </section> <section id="CD013593-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We inspected forest plots visually to consider the direction and magnitude of effects and the degree of overlap between CIs. We used the I² statistic to measure heterogeneity among the trials in each analysis, while acknowledging that there is substantial uncertainty in the I² value when there is only a few studies. If we identified greater than moderate heterogeneity (defined here as an I² greater than 60%) (<a href="./references#CD013593-bbs2-0094" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:14898.">Sterne 2019</a>), we reported it, combined studies using a random‐effects model and explored possible causes by prespecified subgroup analyses.  </p> <p>Additionally, regardless of the I² statistic, if visual inspection of the forest plots revealed any between‐study statistically significant differences in effect direction or magnitude for a given outcome, we used a random‐effects model and explored possible causes using our prespecified subgroup analyses. We further commented on characteristics of any discordant studies that could contribute to the observed discrepancy in magnitude or direction (or both) of effect. </p> </section> <section id="CD013593-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>We created and examined a funnel plot to assess for small‐study biases where we pooled data from at least 10 studies for a given outcome.  </p> </section> <section id="CD013593-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analyses only where this was meaningful, that is if the treatments, participants and underlying clinical questions were similar enough for pooling to make sense. </p> <p>We used a fixed‐effect model, unless the I² statistic was greater than 60%, or our assessment of forest plots as described above suggested more than moderate heterogeneity, in which case we used a random‐effects model in addition to the fixed‐effect model and reported both results. We undertook this approach with the assumption that an I² statistic greater than 60% represented greater than moderate heterogeneity; however, we acknowledge that in certain circumstances the I² statistic may not be sufficiently accurate to detect if significant heterogeneity is present (e.g. small number of studies, variation in direction of effect).  </p> </section> <section id="CD013593-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were unable to carry out meaningful subgroup analysis, due to poor reporting of study characteristics or insufficient number of studies (fewer than 10 studies for statistically significant subgroup analysis recommended) (<a href="./references#CD013593-bbs2-0058" title="DeeksJJ , HigginsJP , AltmanDG .Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. handbook: training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>). </p> <p>For outcomes with moderate heterogeneity, we attempted subgroup analysis for early versus late initiation of UF to determine if this reduced heterogeneity.  </p> <p>If enough data were available, we planned other subgroups such as UF with diuretics versus UF alone, LVEF (i.e. HFpEF versus HFrEF versus HFmrEF) and eGFR on admission. </p> </section> <section id="CD013593-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted a sensitivity analysis for the weight change outcome due to moderate heterogeneity in the meta‐analysis.  If similar levels of precision were identified in this analysis, the outcome was reported narratively. A sensitivity analysis was conducted for percentage change in serum creatinine levels at longest available follow‐up to assess the impact of studies with imputed SDs (borrowed from another study in the meta‐analysis). Further sensitivity analyses were not conducted, as all studies were marked as low risk of bias for missing outcome data and none of the studies had a mixed population. </p> </section> <section id="CD013593-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a summary of findings table using the following outcomes.</p> <p> <ul id="CD013593-list-0008"> <li> <p>All‐cause mortality – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>All‐cause rehospitalisation – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>HF‐related rehospitalisation – up to and including 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>Change in serum creatinine (% change from admission) – 30 days from discharge, and longest available follow‐up. </p> </li> <li> <p>New initiation of long‐term renal replacement therapy at longest available follow‐up.</p> </li> <li> <p>Complications of central line insertion such as pneumothorax, bleeding, central line‐associated bloodstream infection (as defined by study authors), in‐hospital. </p> </li> </ul> </p> <p>In contrast to our Cochrane Review protocol (<a href="./references#CD013593-bbs2-0101" title="SrivastavaM , HarrisonN , CaetanoAF , TanAR , LawM .Ultrafiltration for acute heart failure. Cochrane Database of Systematic Reviews2020, Issue 4. Art. No: CD013593. [DOI: 10.1002/14651858.CD013593]">Srivastava 2020</a>), we included the longest available follow‐up after the review was conducted for our primary outcomes (all‐cause mortality, all‐cause rehospitalisation and HF‐related readmission). This was done in discussion with content experts as these data might be clinically useful. </p> <p>We used the five GRADE considerations (study limitations assessed through overall risk of bias, consistency of effect, imprecision, indirectness and publication bias) to assess the certainty of the evidence as it related to the studies that contributed data to the meta‐analyses for the prespecified outcomes. We used the methods and recommendations described in Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013593-bbs2-0091" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from handbook: training.cochrane.org/handbook/archive/v5.2.">Schünemann 2017</a>), using GRADEpro GDT software (<a href="./references#CD013593-bbs2-0066" title="McMaster University (developed by Evidence Prime)GRADEpro GDT.Hamilton (ON): McMaster University (developed by Evidence Prime).">GRADEpro GDT</a>). We justified all decisions to downgrade the certainty of evidence of studies using footnotes and made comments to aid the reader's understanding of the review where necessary. </p> <p>We made judgements about evidence certainty (AT) with clarifications and discussion by involving two review authors (MS, NH). We justified, documented and incorporated judgements into the reporting of results for each outcome. </p> <p>We undertook post‐hoc analysis and completed risk of bias assessments and GRADE certainty for our primary outcomes at both time points. This was done in consultation with content experts when it was clinically useful.  </p> <p>We extracted study data, formatted our comparisons in data tables, and prepared a summary of findings table before writing the results and conclusions of our review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013593-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013593-sec-0041"></div> <section id="CD013593-sec-0042"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD013593-sec-0082" title="">Characteristics of included studies</a>; <a href="./references#CD013593-sec-0083" title="">Characteristics of excluded studies</a>; <a href="./references#CD013593-sec-0084" title="">Characteristics of studies awaiting classification</a>; and Characteristics of ongoing studies tables. </p> <section id="CD013593-sec-0043"> <h4 class="title">Results of the search</h4> <p>Our systematic search from databases and other sources found 709 references (<a href="#CD013593-fig-0001">Figure 1</a>). After de‐duplication, we screened the titles and abstracts of 497 references. We assessed 65 references for full‐text review and eligibility. Translators applied the inclusion criteria and assisted with data extraction of Russian, Italian and Chinese studies. </p> <div class="figure" id="CD013593-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA Study Selection" data-id="CD013593-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA Study Selection</p> </div> </div> </div> <p>We excluded 17 references and included 14 studies (39 references) with 1190 participants randomised. Nine references are awaiting classification. We attempted to contact 20 authors regarding these nine studies to clarify if inclusion criteria were met, but received no additional information. For the 14 included studies, we contacted the primary authors for each study but obtained no unpublished data.  </p> </section> <section id="CD013593-sec-0044"> <h4 class="title">Included studies</h4> <p>See the <a href="./references#CD013593-sec-0082" title="">Characteristics of included studies</a> table for details of the 14 included studies.   </p> <p>Study inclusion criteria generally focused on signs and symptoms of hypervolaemia, as well as hospital admission diagnosis, to determine the presence of AHF and suitability for the trial.  In most cases, this included a mix of both objective and subjective criteria (oedema, jugular venous distension, chest radiography, invasive haemodynamic measurements, patient‐reported symptoms and others), with no two studies having exactly the same inclusions.  Exclusion criteria in many, but not all, studies screened out people receiving more than one or two doses of intravenous diuretics before randomisation. Many studies, particularly the largest trials (UNLOAD, CARRESS and AVOID), further excluded people with ACS, recent coronary intervention, any signs of haemodynamic instability (i.e. patient subgroups with the highest mortality risk from AHF), or a combination of these. Two studies compared UF with diuretic use to UC (<a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>), while the remaining studies withheld diuretics during UF administration. </p> <p>The proportion of women was approximately 10% to 30% in all studies except <a href="./references#CD013593-bbs2-0010" title="SavT , CecenF , AlbayrakES .The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome. Italian Journal of Urology and Nephrology2017;69(4):400-7. ">Sav 2017</a> (68% in UF group and 40% in UC group were women) and <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a> (45% were women overall). Mean age for the included studies ranged from 57.5 years (<a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a> UC arm) to 75 years (<a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a> UF arm), with the mean of most studies being in the 60s. Studies were generally well‐balanced by age and gender between the UC and UF groups. Five studies reported patients' categorical LVEF (i.e. HFpEF versus HFrEF); all five had mostly people with HFrEF (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>). Five studies (242 participants) were set in Europe (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0010" title="SavT , CecenF , AlbayrakES .The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome. Italian Journal of Urology and Nephrology2017;69(4):400-7. ">Sav 2017</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>; <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a>), one study (10 participants) in South America (<a href="./references#CD013593-bbs2-0013" title="NCT01154504.The role of adrenomedullin on the outcome of severe heart failure: a clinical randomized study. clinicaltrials.gov/ct2/show/NCT01154504 (first received 1 July 2010). SteinAC , MostardaC , AlvesB , De CastroE , AraujoL , EickR , et al.Ultrafiltration treatment in decompensated heart failure: changes in heart rate variability and survival. Hypertension2011;58(5):e64. [DOI: dx.doi.org/10.1161/HYP.0b013e318234a201]">Stein 2011</a>), two studies (234 participants) in Asia (<a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>), and six studies (704 participants) in North America (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>). Most studies had industry funding, included a mix of single and multi‐centre studies, and durations ranging from a few months to years. </p> <p>Studies varied markedly by outcomes assessed. Unfortunately, we were unable to obtain unpublished data for any of the 14 included studies regarding outcomes not commented on in study reports. The most commonly reported outcomes were weight loss (13/14 studies), change in serum creatinine (8/14 studies) and all‐cause mortality (9/14 studies).  </p> <p>Time points of reporting for weight loss and change in serum creatinine varied markedly. Our protocol dichotomised most outcomes into 30 days or less from hospital discharge versus longest available follow‐up in anticipation of such time point heterogeneity.  When considered by this dichotomy, overall heterogeneity by using the I<sup>2</sup> statistic was high for weight change but not for change in serum creatinine.   </p> <p>No studies reported the occurrence of participants requiring mechanical invasive ventilation for respiratory failure at any time point. No included studies reported cardiac mortality for the 30‐day or less time point, but two studies did report this outcome at later time points (i.e. longest available follow‐up). No studies reported percentage change in creatinine at 30 days. At least one included study reported all other primary and secondary outcomes for each of the time points specified in our protocol. </p> </section> <section id="CD013593-sec-0045"> <h4 class="title">Excluded studies</h4> <p>We excluded 19 studies during full‐text screening (see <a href="./references#CD013593-sec-0083" title="">Characteristics of excluded studies</a> table).  The reasons for exclusion in both stages were similar. Most study exclusions were for one of two reasons: the study was not a parallel group RCT of UF versus UC or the population studied consisted of outpatients with HF or both.   </p> <p>With regards to the second reason, the authors noted that by the European Society of Cardiology definition of AHF, being an outpatient does not explicitly exclude AHF (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>). Namely, AHF is defined as signs and symptoms of HF requiring a patient to seek unscheduled care, and such unscheduled care can be in the form of outpatient services (e.g. a person with AHF who is treated in the emergency department and discharged without hospital admission). Nevertheless, the nature of UF as an intervention (prolonged timing, advanced venous access, anticoagulation, specialised personnel, etc.) is such that any clinical trial practically requires a person with AHF to be hospitalised for enrolment.  People with chronic HF being enrolled in the outpatient setting are thus not likely to be representative of our study question. </p> <p>We excluded three studies that met all inclusion criteria for our protocol, but, after contacting the study authors, were noted to have no people enrolled in the UF group (Baxter Healthcare 2008; Gevaert 2011; <a href="./references#CD013593-bbs2-0026" title="NCT00368641.Heart failure and peritoneal ultrafiltration. clinicaltrials.gov/show/NCT00368641 (first received 25 August 2006). ">NCT00368641</a>).  </p> <section id="CD013593-sec-0046"> <h5 class="title">Studies awaiting classification</h5> <p>Nine studies are currently awaiting classification (<a href="./references#CD013593-bbs2-0033" title="ChiCTR-IOR-15006111.Control study early ultrafiltration or diuretics for the treatment of heart failure. www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-15006111 (first received 12 March 2015). ">ChiCTR‐IOR‐15006111</a>; <a href="./references#CD013593-bbs2-0032" title="ChiCTR2000035430.A randomized controlled trial for FQ-16 heart failure ultrafiltration dehydration device in the treatment of patients with heart failure diuretic resistance. www.chictr.org.cn/hvshowproject.aspx?id=47274 (first received 11 August 2020). ">ChiCTR2000035430</a>; <a href="./references#CD013593-bbs2-0034" title="KoratalaA .No difference in sodium removal with ultrafiltration therapy versus conventional diuretic therapy in patients with acute heart failure. Cardiology (Switzerland)2016;134(Suppl 1):420. ">Koratala 2016</a>; <a href="./references#CD013593-bbs2-0035" title="MukharliamovNM , MareevVI , AidargalievaNE , SazonovaLN , MasenkoVP .Clinical and hemodynamic effectiveness of isolated ultrafiltration in the treatment of patients with severe cardiac insufficiency. Terapevticheskii Arkhiv1985;57(10):85-9. ">Mukharlimov 1985</a>; <a href="./references#CD013593-bbs2-0036" title="NCT01140399.REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure. clinicaltrials.gov/show/NCT01140399 (first received 9 June 2010). ">NCT01140399</a>; <a href="./references#CD013593-bbs2-0037" title="NCT01457053.Assessment of coronary flow reserve in heart failure patients after ultrafiltration versus diuretics. www.clinicaltrials.gov/ct2/show/NCT01457053 (first posted 21 October 2011). ">NCT01457053</a>; <a href="./references#CD013593-bbs2-0038" title="NCT01863511.Tolvaptan/ultrafiltration in the treatment of acute heart failure. clinicaltrials.gov/show/NCT01863511 (first received 29 May 2013). ">NCT01863511</a>; <a href="./references#CD013593-bbs2-0039" title="NCT03161158.PURE-HF: peripheral Ultrafiltration for the RElief From Congestion in Heart Failure. clinicaltrials.gov/show/NCT03161158 (first received 19 May 2017). ">NCT03161158</a>; <a href="./references#CD013593-bbs2-0040" title="WeinsteinDM , O'NeillJO , CesarL , PaganiniE , TaylorDO .The hemodynamic and renal effects of ultrafiltration for severe heart failure exacerbations – SCUF/HF trial. Journal of the American Society of Nephrology2004;15:593A. ">Weinstein 2004</a>; see <a href="./references#CD013593-sec-0084" title="">Characteristics of studies awaiting classification</a> table).  All were studies where further information was needed from the study authors to determine inclusion or exclusion, but in which the authors had not responded to email requests at the time of publication. None had retrievable full study reports (e.g. all were clinical trial registrations or abstract only, or both). There was no clear exclusion reason for any. Two had unclear methodology and were deemed to need a more comprehensive report of methods to clarify if they met the inclusion criteria (<a href="./references#CD013593-bbs2-0034" title="KoratalaA .No difference in sodium removal with ultrafiltration therapy versus conventional diuretic therapy in patients with acute heart failure. Cardiology (Switzerland)2016;134(Suppl 1):420. ">Koratala 2016</a>; <a href="./references#CD013593-bbs2-0035" title="MukharliamovNM , MareevVI , AidargalievaNE , SazonovaLN , MasenkoVP .Clinical and hemodynamic effectiveness of isolated ultrafiltration in the treatment of patients with severe cardiac insufficiency. Terapevticheskii Arkhiv1985;57(10):85-9. ">Mukharlimov 1985</a>). The remaining seven appeared to meet the inclusion criteria but did not have reported results, most being clinical trials registered but terminated for poor enrolment. In each of those seven cases, we were able to discern that it was possible at least some participants were enrolled and thus could have unpublished data that can be added to the review when/if contact is possible with the authors. </p> </section> <section id="CD013593-sec-0047"> <h5 class="title">Ongoing studies</h5> <p>We found no ongoing studies.</p> </section> </section> </section> <section id="CD013593-sec-0048"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the included studies using the RoB 2 tool (<a href="./references#CD013593-bbs2-0094" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:14898.">Sterne 2019</a>) for each of the outcomes included in <a href="./full#CD013593-tbl-0001">summary of findings Table 1</a>, and in the forest plots for these outcomes and the <a href="./references#CD013593-sec-0085" title="">Risk of bias (tables)</a>. Detailed risk of bias assessments can be found as a supplemental file (<a href="https://doi.org/10.6084/m9.figshare.15477048" target="_blank">RoB assessments</a>). </p> <p>Overall, the risk of bias from the randomisation process and selection of reported results was low. There was minimal missing data for short‐term follow‐up, however there was bias from missing data when looking at longer term follow‐up (e.g. all‐cause rehospitalisation at longest available follow‐up). These missing data at long‐term follow‐up also influenced how that outcome was measured. Additionally, there was high risk of bias due to deviations from intended interventions, with crossover between the two arms noted in some studies.  </p> <p>While outcomes in many studies were at high risk of bias or had some concerns, in nearly all of these cases the bias would be expected to favour UC over UF.  Given that the comparison was UF versus UC and was unblinded, the particular issue with crossovers in the largest trials (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>) led to participants with UF being treated as UC (but still analysed as UF, given an intention‐to‐treat analysis).  Towards the same effect, in studies such as CARRESS participants assigned to UC by protocol could have crossed over to UF (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>). It is unclear in how many such participants this occurred, since this specific type of crossover was protocol‐specified rather than an incidental protocol violation (the latter of which may also have occurred).  </p> <p>As another example in which bias may have been present, but ultimately would be expected to favour UC and not UF, participants in the CARRESS study were more likely to have an ischaemic cause of AHF in the UF group than the UC group (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>). Ischaemia as a precipitant of AHF is one of the strongest predictors of poor short‐ and long‐term outcomes, including mortality (<a href="./references#CD013593-bbs2-0047" title="ArrigoM , GayatE , ParenicaJ , IshiharaS , ZhangJ , ChoiDJ , et al.Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. European Journal of Heart Failure2017;19(2):201-8.">Arrigo 2017</a>; <a href="./references#CD013593-bbs2-0063" title="FonarowGC , AbrahamWT , AlbertNM , StoughWG , GheorghiadeM , GreenbergBH , et al.Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. INTEMED2008;168(8):847-54.">Fonarow 2008</a>; <a href="./references#CD013593-bbs2-0067" title="HarrisonN , FavotM , LevyP .The role of troponin for acute heart failure. Current Heart Failure Reports2019;16(1):21-31.">Harrison 2019</a>). </p> </section> <section id="CD013593-sec-0049"> <h3 class="title" id="CD013593-sec-0049">Effects of interventions</h3> <p>See: <a href="./full#CD013593-tbl-0001"><b>Summary of findings 1</b> Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</a> </p> <p>There were few disagreements between review authors regarding study selection, data extraction or risk of bias assessments. All were resolved with consensus. For the comparison of UF to UC, the effects of intervention were pooled as MDs for continuous outcomes and RRs for dichotomous outcomes.  See details of the main results in the <a href="./full#CD013593-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD013593-sec-0050"> <h4 class="title">All‐cause mortality</h4> <p>Three studies (286 participants randomised) reported all‐cause mortality at a follow‐up of 30 days or less (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>). We are uncertain about the effects of UF on all‐cause mortality at 30 days or less (RR 0.61, 95% CI 0.13 to 2.85; very low‐certainty evidence; <a href="./references#CD013593-fig-0003" title="">Analysis 1.1</a>). Event rates were low in each arm (1/134 in UF group versus 3/152 in UC group). </p> <p>Nine studies (987 participants randomised) reported all‐cause mortality at longest available follow‐up, varying from 30 days in <a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a> to one year in <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a> (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>; <a href="./references#CD013593-bbs2-0013" title="NCT01154504.The role of adrenomedullin on the outcome of severe heart failure: a clinical randomized study. clinicaltrials.gov/ct2/show/NCT01154504 (first received 1 July 2010). SteinAC , MostardaC , AlvesB , De CastroE , AraujoL , EickR , et al.Ultrafiltration treatment in decompensated heart failure: changes in heart rate variability and survival. Hypertension2011;58(5):e64. [DOI: dx.doi.org/10.1161/HYP.0b013e318234a201]">Stein 2011</a>). UF may have little to no effect on all‐cause mortality at longest available follow‐up, but the CI also included appreciable benefit or harm (RR 1.00, 95% CI 0.73 to 1.36; low‐certainty evidence; <a href="./references#CD013593-fig-0004" title="">Analysis 1.2</a>). </p> </section> <section id="CD013593-sec-0051"> <h4 class="title">All‐cause rehospitalisation</h4> <p>Three studies (337 participants randomised) reported all‐cause rehospitalisation at 30‐day follow‐up or less (<a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>). UF may reduce all‐cause rehospitalisation at 30‐day follow‐up or less (RR 0.76, 95% CI 0.53 to 1.09; low‐certainty evidence; <a href="./references#CD013593-fig-0005" title="">Analysis 1.3</a>). </p> <p>Six studies (612 participants randomised) reported all‐cause rehospitalisation at longest available follow‐up (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>). UF may slightly reduce all‐cause mortality at longest available follow‐up (RR 0.91, 95% CI 0.79 to 1.05; low‐certainty evidence; <a href="./references#CD013593-fig-0006" title="">Analysis 1.4</a>). </p> </section> <section id="CD013593-sec-0052"> <h4 class="title">Heart failure‐related rehospitalisation</h4> <p>Two studies (395 participants randomised) reported HF‐related rehospitalisations at 30 days or less from discharge (<a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>). UF may reduce HF‐related rehospitalisation at 30 days or less (RR 0.62, 95% CI 0.37 to 1.04; low‐certainty evidence; <a href="./references#CD013593-fig-0007" title="">Analysis 1.5</a>). </p> <p>Four studies (636 participants randomised) reported HF‐related rehospitalisations at longest available follow‐up (<a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>). UF probably reduces the rate of HF‐related rehospitalisations at longest available follow‐up (RR 0.69, 95% CI 0.53 to 0.90; moderate‐certainty evidence; <a href="./references#CD013593-fig-0008" title="">Analysis 1.6</a>). This corresponded to an absolute risk reduction (ARR) of 10.9%, or a number needed to treat for an additional beneficial outcome (NNTB) of 10, for the prevention of HF‐related rehospitalisation in this population. </p> </section> <section id="CD013593-sec-0053"> <h4 class="title">Weight change </h4> <p>Thirteen studies (1126 participants randomised) reported weight change from baseline (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0010" title="SavT , CecenF , AlbayrakES .The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome. Italian Journal of Urology and Nephrology2017;69(4):400-7. ">Sav 2017</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>; <a href="./references#CD013593-bbs2-0013" title="NCT01154504.The role of adrenomedullin on the outcome of severe heart failure: a clinical randomized study. clinicaltrials.gov/ct2/show/NCT01154504 (first received 1 July 2010). SteinAC , MostardaC , AlvesB , De CastroE , AraujoL , EickR , et al.Ultrafiltration treatment in decompensated heart failure: changes in heart rate variability and survival. Hypertension2011;58(5):e64. [DOI: dx.doi.org/10.1161/HYP.0b013e318234a201]">Stein 2011</a>; <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a>). The certainty of the evidence was very low due to moderate heterogeneity, wide CIs, high imprecision and methodological limitations. We are uncertain whether UF affects weight change (MD 1.74 kg, 95% CI −0.65 to 4.12; very low‐certainty evidence; <a href="./references#CD013593-fig-0009" title="">Analysis 1.7</a>).  </p> <p>The initial fixed‐effect model resulted in a high level of heterogeneity (I<sup>2</sup> = 96%), which persisted when a random‐effects model was applied (I<sup>2</sup> = 96%).  A sensitivity analysis according to overall risk of bias was conducted due to the high heterogeneity in the meta‐analysis (as specified by our protocol). This sensitivity analysis returned similar levels of imprecision. However, removing <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a> from the meta‐analysis substantially reduced the I<sup>2</sup> statistic to 50% (MD 1.28 kg, 95% CI 0.34 to 2.22; 1087 participants randomised). Due to this study's poor methodological quality and small sample size (39 participants randomised), it is possible that the effect for this study was spuriously inflated (MD 8.18 kg, 95% CI 7.57 to 8.79), and led to the high heterogeneity when pooled with the other studies.   </p> <p>We attempted subgroup analysis for early versus late initiation of UF; however, this further increased the heterogeneity. Other planned subgroups had included UF with diuretics versus UF alone; however, only one study clearly allowed both UF and diuretics throughout the intervention (<a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>), therefore analysis for this subgroup was not performed. Clear subgroups by LVEF (i.e. HFpEF versus HFrEF versus HFmrEF) and eGFR on admission could not be done due to poor and inconsistent reporting. All the populations, interventions and outcome measurements were deemed reasonably similar. Therefore, in the absence of conclusive results from the sensitivity analysis and subgroup analysis, we have maintained the pooled random‐effects estimate and accounted for the inconsistency in the GRADE assessment.   </p> <p>Visual inspection of the funnel plot showed slight asymmetry (<a href="#CD013593-fig-0002">Figure 2</a>). While this could be due to publication bias, there is no clear direction of effect. It is more likely this asymmetry is due to poor methodological quality leading to spuriously inflated effects in smaller studies (<a href="./references#CD013593-bbs2-0013" title="NCT01154504.The role of adrenomedullin on the outcome of severe heart failure: a clinical randomized study. clinicaltrials.gov/ct2/show/NCT01154504 (first received 1 July 2010). SteinAC , MostardaC , AlvesB , De CastroE , AraujoL , EickR , et al.Ultrafiltration treatment in decompensated heart failure: changes in heart rate variability and survival. Hypertension2011;58(5):e64. [DOI: dx.doi.org/10.1161/HYP.0b013e318234a201]">Stein 2011</a>; <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a>).  </p> <div class="figure" id="CD013593-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="original image" data-id="CD013593-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD013593-sec-0054"> <h4 class="title">Need for mechanical invasive ventilation</h4> <p>No studies reported the need for mechanical ventilation, at any time point, for the comparison of UF versus UC. </p> </section> <section id="CD013593-sec-0055"> <h4 class="title">Hospital length of stay</h4> <p>Five studies (341 participants randomised) reported hospital length of stay (<a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>; <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a>). UF may have little to no effect on hospital length of stay between UF versus UC (MD −0.24 days, 95% CI −0.78 to 0.30; <a href="./references#CD013593-fig-0010" title="">Analysis 1.8</a>). <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a> reported a non‐significant difference in length of stay as a median without reporting a mean or SD and was therefore unable to be pooled in the meta‐analysis (6 days with UF versus 5 days with UC; P = 0.106). Similarly, <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a> reported a median rather than a mean and SD (4.53 days with UF versus 9.61 days with UC; P &lt; 0.001) and was unable to be pooled in the meta‐analysis. </p> </section> <section id="CD013593-sec-0056"> <h4 class="title">Cardiac mortality</h4> <p>One study (146 participants randomised) reported cardiac mortality up to 30 days from discharge (<a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>). UF may have little to no effect for reducing cardiac mortality (RR 0.19, 95% CI 0.01 to 3.99; <a href="./references#CD013593-fig-0011" title="">Analysis 1.9</a>).  </p> <p>Two studies (367 participants randomised) reported cardiac mortality at longest available follow‐up (<a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>). UF may have little to no effect for reducing cardiac mortality at the longest available follow‐up (RR 1.18, 95% CI 0.53 to 2.60; <a href="./references#CD013593-fig-0012" title="">Analysis 1.10</a>). </p> <p>One study (200 participants randomised) reported three deaths in the UF arm and five in the UC arm due to HF (<a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>). Deaths from other cardiac causes, such as myocardial infarction, were reported only for the control arm (one in the UC arm). Because of this, we could not pool the study results under cardiac mortality for either time point. </p> </section> <section id="CD013593-sec-0057"> <h4 class="title">Change in serum creatinine</h4> <p>One study (221 participants randomised) reported change in creatinine at 30 days (<a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>). UF may have little or no difference in percentage change in serum creatinine levels at 30‐day follow‐up (MD 14%, 95% CI −12% to 4%).   </p> <p>Nine studies (764 participants randomised) reported a percentage change in serum creatinine levels at longest available follow‐up (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0010" title="SavT , CecenF , AlbayrakES .The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome. Italian Journal of Urology and Nephrology2017;69(4):400-7. ">Sav 2017</a>). UF may have little or no difference in percentage change in serum creatinine levels at the longest available follow‐up (MD 2%, 95% CI −11% to 15%; <a href="./references#CD013593-fig-0014" title="">Analysis 1.12</a>). Greater than 30% difference is clinically meaningful (<a href="./references#CD013593-bbs2-0090" title="SchmidtM , MansfieldKE , BhaskaranK , NitschD , SørensenHT , SmeethL , et al.Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ (Clinical Research Ed.)2017;356:j791.">Schmidt 2017</a>).  </p> <p>We conducted a sensitivity analysis for the percentage change in serum creatinine levels at longest available follow‐up to assess the impact of studies with imputed SDs (borrowed from another study in the meta‐analysis). However, the sensitivity analysis showed that the overall result and conclusions were not affected by the studies with imputed SDs.   </p> </section> <section id="CD013593-sec-0058"> <h4 class="title">New initiation of renal replacement therapy (at longest available follow‐up)</h4> <p>Four studies (322 participants randomised) reported the rates of new initiation of renal replacement therapy at longest available follow‐up (<a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>). UF may increase the risk of new initiation of renal replacement therapy (RR 1.42, 95% CI 0.42 to 4.75; low‐certainty evidence; <a href="./references#CD013593-fig-0015" title="">Analysis 1.13</a>). Event rates were low in each arm (5/156 in UF group versus 4/166 in UC group). One study reported zero events in both arms (0/15 in UF group versus 0/15 in UC group) (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>).  </p> </section> <section id="CD013593-sec-0059"> <h4 class="title">Major bleeding in‐hospital</h4> <p>One study (200 participants randomised) reported the rates of major bleeding (as defined by the study authors) (<a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>). There was no evidence of a difference in UF versus UC for reducing the rates of major bleeding (RR 0.14, 95% CI 0.02 to 1.14; <a href="./references#CD013593-fig-0016" title="">Analysis 1.14</a>). The definition of major bleeding was left to the reporting of bleeding events by the study authors per our protocol, and due to a lack of consistency in terminology across studies we chose to assess study‐defined major bleeding with bleeding events in other studies. We noted that this limits interpretation of this outcome, but was done given that multiple other studies reported no bleeding events. Five studies reported zero events in both arms (0/20 in UF group versus 0/20 UC group, <a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; 0/15 in UF group versus 0/15 in UC group, <a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; 0/40 in UF group versus 0/60 in UC group, <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; 0/27 in UF group versus 0/29 in UC group, <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; 0/10 in UF group versus 0/20 in UC group, <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>).  </p> </section> <section id="CD013593-sec-0060"> <h4 class="title">Complications of central line insertion</h4> <p>Six studies (779 participants randomised) reported the rate of in‐hospital complications related to central venous access (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0002" title="BartBA , GoldsmithSR , LeeKL , GivertzMM , O'ConnorCM , BullDA , et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine2012;367(24):2296-304. [DOI: dx.doi.org/10.1056/NEJMoa1210357]BartBA , GoldsmithSR , LeeKL , StevensonLW , O'ConnorCM , BullDA , et al.Cardiorenal rescue study in acute decompensated heart failure: results of CARRESS-HF, for the heart failure clinical research network. Circulation2012;126(23):2786. [DOI: dx.doi.org/10.1161/CIR.0b013e318278c90d]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A870. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931411-6]CarterS , BartB , GoldsmithS , DraznerM , TangWH , GrodinJ .Disconnection between volume loss and increasing serum bicarbonate during treatment for acutely decompensated heart failure: a per-protocol analysis of CARRESS-HF. Journal of the American College of Cardiology2018;71(11 Suppl 1):A774. [DOI: dx.doi.org/10.1016/S0735-1097%2818%2931315-9]FudimM , BrooksbankJ , GiczewskaA , GreeneSJ , GrodinJL , MartensP , et al.Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF. Journal of the American Heart Association2020;9(24):e015752. [DOI: 10.1161/JAHA.119.015752]GrodinJL , CarterS , BartBA , GoldsmithSR , DraznerMH , TangWH .Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. European Journal of Heart Failure2018;20(7):1148-56. [DOI: dx.doi.org/10.1002/ejhf.1158]KitaiT , GrodinJL , KimYH , TangWH .Impact of ultrafiltration on serum sodium homeostasis and its clinical implication in patients with acute heart failure, congestion, and worsening renal function. Circulation. Heart Failure2017;10(2):e003603. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003603]NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/ct2/show/NCT00608491 (first posted 6 February 2008). NCT00608491.Effectiveness of ultrafiltration in treating people with acute decompensated heart failure and cardiorenal syndrome (the CARRESS study). clinicaltrials.gov/show/NCT00608491 (first received 6 February 2008). RaoVS , AhmadT , Brisco-BacikMA , BonventreJV , WilsonFP , SiewED , et al.Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circulation. Heart Failure2019;12(6):e005552. [DOI: dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005552]">Bart 2012</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>). There is an uncertain effect of UF on the risk of central line complications (RR 4.16, 95% CI 1.30 to 13.30; very low‐certainty evidence; <a href="./references#CD013593-fig-0017" title="">Analysis 1.15</a>). The absolute increase in risk of a central line‐related complication, as defined by the study reports for UF versus UC, was 2.43% (number needed to treat for an additional harmful outcome (NNTH) 42). Two studies reported zero events in both arms (0/15 in UF group versus 0/15 in UC group, <a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; 0/27 in UF group versus 0/29 in UC group, <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>). <a href="./references#CD013593-bbs2-0007" title="HannaMA , TangWH , TeoBW , O'NeillJO , WeinsteinDM , LauSM , et al.Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congestive Heart Failure2012;18(1):54-63. [DOI: dx.doi.org/10.1111/j.1751-7133.2011.00231.x]NCT00288587.Extracorporeal ultrafiltration (UF) vs. usual and customary care for patients with severe heart failure (HF). clinicaltrials.gov/show/nct00288587 (first received 8 February 2006). ">Hanna 2012</a> alluded to central line complications but no numbers were able to allow pooling of the data. </p> <p>No studies evaluated tertiary outcomes such as healthcare utilisation or undertook a cost–benefit analysis. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013593-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013593-sec-0061"></div> <section id="CD013593-sec-0062"> <h3 class="title" id="CD013593-sec-0062">Summary of main results</h3> <p>There is an uncertain effect of UF on all‐cause mortality at 30 days or less due to small sample size. At the longest available follow‐up, UF may have little to no effect on all‐cause mortality. </p> <p>UF may reduce all‐cause rehospitalisation and HF‐related rehospitalisation at 30 days or less.  At the longest available follow‐up, UF probably reduces HF‐related rehospitalisations with an absolute risk reduction of 10.9%, and a NNTB of 10.  </p> <p>There is very low‐certainty evidence for the effect of UF on weight change, and its effect is unclear. We found moderate heterogeneity when measuring weight change, and inconsistent results were observed across the thirteen different studies. UF may have little to no effect on hospital length of stay from the five studies that researched this (<a href="./references#CD013593-bbs2-0003" title="BartoneC , MenonSG , KereiakesDJ , O'BrienTM , MazurW , McClellanM , et al.Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. Journal of Cardiac Failure2010;16(8 Suppl 1):S106. [DOI: dx.doi.org/10.1016/j.cardfail.2010.06.370]ChungE , BartoneC , MenonS , MazurW , O'BrienT , KereiakesD .Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. European Heart Journal2010;31(Suppl 1):919. [DOI: dx.doi.org/10.1093/eurheartj/ehq290]ChungES , O'BrienTM , MenonS , BartoneC , MazurW , KereiakesDJ .A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.  Korean Circulation Journal 2014;44(3):156-61. ">Chung 2010</a>; <a href="./references#CD013593-bbs2-0004" title="CostanzoMR , GuglinME , SaltzbergMT , JessupML , BartBA , TeerlinkJR , et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology2007;49(6):675-83. CostanzoMR , SaltzbergMT , JessupM , TeerlinkJR , SobotkaPA .Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of Cardiac Failure2010;16(4):277-84. [DOI: dx.doi.org/10.1016/j.cardfail.2009.12.009]NCT00124137.Ultrafiltration versus intravenous (IV) diuretics for patients hospitalized for acute decompensated heart failure: (UNLOAD). clinicaltrials.gov/show/NCT00124137 (first received 27 July 2005). RogersHL , MarshallJ , BockJ , DowlingTC , FellerE , RobinsonS , et al.A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. Journal of Cardiac Failure2008;14(1):1-5. [DOI: dx.doi.org/10.1016/j.cardfail.2007.09.007]">Costanzo 2010</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>; <a href="./references#CD013593-bbs2-0014" title="Tabak'ianEA , ZarubaAI , MiasnikovRP , AtaullakhanovaDM , KukharchukVV .Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure. Kardiologiia2010;50(2):30-5. TabakyanEA , ZrubaY , RogozaAN , AtaullakhanovaDM , KukharchukVV .Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. Terapevticheskii Arkhiv2010;82(8):24-9. ">Tabak'ian 2010</a>). Cardiac mortality was not well researched. Two studies assessed cardiac mortality, finding that UF may have little to no effect on this outcome (<a href="./references#CD013593-bbs2-0005" title="CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC. Heart Failure2016;4(2):95-105. CostanzoMR , NegoianuD , JaskiBE , BartBA , HeywoodJT , AnandIS , et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure (AVOID-HF) trial. Journal of Cardiac Failure2015;21(11):937-9. NCT01474200.Study of heart failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment. clinicaltrials.gov/show/NCT01474200 (first received 18 November 2011). ">Costanzo 2015</a>; <a href="./references#CD013593-bbs2-0012" title="ShenX , LiL , MaJ , ZhangB , GeZ , LiuX , et al.Safety and efficacy of ultrafiltration on heart failure patients with reduced ejection fraction and diuretic resistance: results from a single-center randomized controlled trial. Chinese Journal of Cardiology2021;49(4):340-4. ShenXL , ZuLB , LiL , MaJ , ZhangBJ , JiangSB .The efficacy and safety of ultrafiltration for patients with heart failure: results from a single-center randomized controlled study. Zhonghua Xin Xue Guan Bing za Zhi2017;45(7):608-12. [DOI: dx.doi.org/10.3760/cma.j.issn.0253-3758.2017.07.010]">Shen 2017</a>). No studies were found that evaluated need for mechanical ventilation. This could reflect that such acutely unwell patients have been excluded from the research cohort, or that this patient focused outcome has not been adequately researched. </p> <p>With regard to adverse effects, UF may increase the risk of new initiation of renal replacement therapy at longest available follow‐up. UF may have little to no effect on serum creatinine change at 30 days since discharge or at the longest available follow‐up. There is an uncertain effect of UF on complications from central line complications. Major bleeding events were rare across UF and UC group. Five studies reported zero events in both arms (<a href="./references#CD013593-bbs2-0001" title="BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial. Journal of Cardiac Failure2004;10(4):S23. [DOI: 10.1016/j.cardfail.2004.06.018]BartBA , BoyleA , BankAJ , AnandI , OlivariMT , KraemerM , et al.Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. Journal of the American College of Cardiology2005;46(11):2043-6. BartBA .Ultrafiltration for health failure. Cardiology Review 2006;23(7):16-9. ">Bart 2005</a>; <a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>; <a href="./references#CD013593-bbs2-0008" title="HuJ , WanQ , ZhangY , ZhouJ , LiM , JiangL , et al.Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders2020;20(1):447. WanQL , HuJY , ZhouJ , LiMM , ZhangY , YuanF .Efficacy of early ultrafiltration in acute decompensated heart failure patients with volume overload. Journal of Shanghai Jiaotong University (Medical Science)2021;41(3):344-9. [DOI: 10.3969/j.issn.1674-8115.2021.03.010]">Hu 2020</a>; <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>; <a href="./references#CD013593-bbs2-0011" title="ŞekerA , KayatasM , HuzmeliC , CandanF , YilmazMB .Comparison of ultrafiltration and intravenous diuretic therapies in patients hospitalized for acute decompensated biventricular heart failure. Turkish Journal of Nephrology2016;25:79-87. ">Seker 2016</a>).  </p> <p>No studies were found that looked at cost–benefit analysis. This is important given the significant healthcare and resource utilisation required for UF. </p> <p>We acknowledge that follow‐up times for outcomes assessed at longest available follow‐up (all‐cause mortality, all‐cause rehospitalisation, cardiac mortality, HF‐related rehospitalisation, change in serum creatinine and new initiation of long‐term renal replacement) were heterogeneous, varying from 48 hours to one year. However, we chose to assess outcomes at both 30 days or less and longest available follow‐up. Thirty days appeared to be the most reasonable time point as we expect UF to impact short‐ and medium‐term outcomes rather than modify the HF disease course (see <a href="#CD013593-sec-0012">How the intervention might work</a>). Other meta‐analyses on the topic have also reported outcomes at the longest available follow‐up, which we have included (<a href="./references#CD013593-bbs2-0099" title="WobbeB , WagnerJ , SzabóDK , RostásI , FarkasN , GaramiA , et al.Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews2021;26(3):577-85.">Wobbe 2021</a>).  </p> </section> <section id="CD013593-sec-0063"> <h3 class="title" id="CD013593-sec-0063">Overall completeness and applicability of evidence</h3> <p>This review summarises the current evidence of UF in AHF. It evaluates the effect of UF on various clinical outcomes, with very low‐ to moderate‐certainty evidence available. We could not perform meaningful subgroup analysis to look at which patient setting or population UF may be indicated in. This was because of limited studies as well as poor and inconsistent reporting of characteristics such as proportion of chronic kidney disease or HFrEF/HFmrEF/HFpEF. Additionally, many studies were performed before HFmrEF was introduced as a formal classification in 2016 by the European Society of Cardiology guidelines (<a href="./references#CD013593-bbs2-0086" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129-200.">Ponikowski 2016</a>). </p> <p>A key limitation is that the studies in this review may have underestimated the true clinical benefit of UF. UF works to improve diuretic responsiveness, and should be a complimentary therapy to UC, rather than an alternative option. In many studies, such as the CARRESS‐HF and UNLOAD trials, loop diuretics were not allowed or were discontinued during UF treatment. It is likely that when the two strategies are used in association, a better clinical outcome could be demonstrated. </p> <p>Additionally, many studies focused on endpoints such as all‐cause mortality and readmission. This may not reflect the true effect of UF, since we do not expect UF to alter the disease course. Such outcomes may focus on unrelated events since people with AHF can be admitted for a variety of reasons.  HF‐related rehospitalisation and mortality are better endpoints for evaluating the impact of UF, however this was poorly reported with only two (HF‐related rehospitalisation) and four (mortality) studies.  </p> <p>With regards to adverse outcomes, many studies focused on serum creatinine change in hospital. Our understanding of AHF has evolved over time, and it is now recognised that transient rise in serum creatinine during AHF decongestion therapy is not necessarily indicative of acute kidney injury, but can represent a haemodynamic change in glomerular filtration rate (<a href="./references#CD013593-bbs2-0043" title="AhmadT , JacksonK , RaoVS , TangWH , Brisco-BacikMA , ChenHH , et al.Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation2018;137(19):2016-8.">Ahmad 2018</a>). Only four studies reported the rate at which patients required long‐term renal replacement therapy. This patient‐centred outcome would be a useful endpoint to assess in future studies more robustly. </p> <p>The results from this review can be applied to people with AHF who have symptoms of congestion, without haemodynamic instability or significant comorbidities. People with severe renal impairment, acute coronary syndrome, systemic infection or marked hypotension were often excluded from the research cohort. Results from this review cannot be applied to this patient subgroup, which have the highest mortality risk from AHF. </p> <p>All studies were performed in middle‐ and upper‐income countries, so caution should be applied when generalising results to low‐income countries. </p> </section> <section id="CD013593-sec-0064"> <h3 class="title" id="CD013593-sec-0064">Quality of the evidence</h3> <p>Overall, there was very low‐ to moderate‐certainty evidence from the studies. Our confidence in the estimates was reduced due to differences in the study settings, methodological limitations of the studies, significant variability in the study results and imprecise results with wide CLs that included no effect.  </p> <p>High risk of bias in the various study methodology impacts how confident we are drawing conclusions from the evidence found. The major methodological limitations came from deviations from intended protocol from crossovers, which mostly favoured UC over UF across all outcomes (see <a href="#CD013593-sec-0048">Risk of bias in included studies</a>  for further detail). Bias is also introduced when evaluating some safety endpoints of complications of central line insertion or need for long‐term dialysis. Loss to follow‐up at longer time points is particularly important when evaluating need for long‐term dialysis, and the inherent unblinded nature of this intervention can bring in selection or measurement bias when assessing central line complications.  </p> <p>The study limitations as well as the marked heterogeneity between the studies contributed to the conflicting results found in the effects of UF. There were differences in selection of the study population and exclusion criteria, heterogeneity of the indications for the use of UF as well as the UF protocols implemented, and high variability in the conventional therapy used for the control group. This needs to be considered when interpreting the effects of intervention, and therefore we have downgraded our certainty of evidence.  </p> </section> <section id="CD013593-sec-0065"> <h3 class="title" id="CD013593-sec-0065">Potential biases in the review process</h3> <p>While our search strategy was comprehensive, there is a chance of publication bias affecting our review. A secondary outcome of weight change was the only outcome with more than 10 studies pooled, and was assessed for publication bias with a funnel plot. This showed slight asymmetry, which could be due to multiple reasons. This includes a non‐reporting bias as well as likelihood of small trials with poor methodological rigour tending to show a larger intervention effect (<a href="./references#CD013593-bbs2-0059" title="EggerM , SmithGD , SchneiderM , MinderC .Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>).  </p> <p>Within the eligible studies, there are nine awaiting classification, pending further information from authors. Seven of these studies appeared to meet criteria based on their trial records without any reported results. It is possible they have unpublished data that have not been included. At the data collection stage, no unpublished or individual‐level data could be obtained despite attempts to contact the authors. These unpublished data have the potential to introduce publication bias.  Future updates to this review will benefit greatly if such unpublished data are able to be obtained. </p> </section> <section id="CD013593-sec-0066"> <h3 class="title" id="CD013593-sec-0066">Agreements and disagreements with other studies or reviews</h3> <p>UF may have little effect on all‐cause mortality in the long‐term, which is consistent with other reviews (<a href="./references#CD013593-bbs2-0070" title="JainA , AgrawalN , KazoryA .Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Failure Reviews2016;21(5):611-9.">Jain 2016</a>; <a href="./references#CD013593-bbs2-0092" title="ShiX , BaoJ , ZhangH , WangH , LiL , ZhangY .Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews2019;24(6):927.">Shi 2019</a>; <a href="./references#CD013593-bbs2-0093" title="SiddiquiWJ , KohutAR , HasniSF , GoldmanJM , SilvermanB , KelepourisE , et al.Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Failure Reviews2017;22(6):685-98.">Siddiqui 2017</a>; <a href="./references#CD013593-bbs2-0099" title="WobbeB , WagnerJ , SzabóDK , RostásI , FarkasN , GaramiA , et al.Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews2021;26(3):577-85.">Wobbe 2021</a>). Most reviews noted a reduction in all‐cause rehospitalisation, and particularly HF‐related rehospitalisation with UF (<a href="./references#CD013593-bbs2-0070" title="JainA , AgrawalN , KazoryA .Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Failure Reviews2016;21(5):611-9.">Jain 2016</a>; <a href="./references#CD013593-bbs2-0072" title="KwokCS , WongCW , RushtonCA , AhmedF , CunningtonC , DaviesSJ , et al.Ultrafiltration for acute decompensated cardiac failure: a systematic review and meta-analysis. International Journal of Cardiology2017;228:122-8.">Kwok 2017</a>; <a href="./references#CD013593-bbs2-0092" title="ShiX , BaoJ , ZhangH , WangH , LiL , ZhangY .Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews2019;24(6):927.">Shi 2019</a>; <a href="./references#CD013593-bbs2-0093" title="SiddiquiWJ , KohutAR , HasniSF , GoldmanJM , SilvermanB , KelepourisE , et al.Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Failure Reviews2017;22(6):685-98.">Siddiqui 2017</a>; <a href="./references#CD013593-bbs2-0099" title="WobbeB , WagnerJ , SzabóDK , RostásI , FarkasN , GaramiA , et al.Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews2021;26(3):577-85.">Wobbe 2021</a>).  </p> <p>There were conflicting results for weight loss in previous reviews. Some reported no or minimal difference (<a href="./references#CD013593-bbs2-0070" title="JainA , AgrawalN , KazoryA .Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Failure Reviews2016;21(5):611-9.">Jain 2016</a>; <a href="./references#CD013593-bbs2-0072" title="KwokCS , WongCW , RushtonCA , AhmedF , CunningtonC , DaviesSJ , et al.Ultrafiltration for acute decompensated cardiac failure: a systematic review and meta-analysis. International Journal of Cardiology2017;228:122-8.">Kwok 2017</a>; <a href="./references#CD013593-bbs2-0092" title="ShiX , BaoJ , ZhangH , WangH , LiL , ZhangY .Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews2019;24(6):927.">Shi 2019</a>) compared to others finding significant weight loss with UF (<a href="./references#CD013593-bbs2-0052" title="ChenHY , ChouKJ , FangHC , ChenCL , HsuCY , HuangWC , et al.Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials. Nephron2015;129(3):189-96.">Chen 2015</a>; <a href="./references#CD013593-bbs2-0070" title="JainA , AgrawalN , KazoryA .Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Failure Reviews2016;21(5):611-9.">Jain 2016</a>; <a href="./references#CD013593-bbs2-0093" title="SiddiquiWJ , KohutAR , HasniSF , GoldmanJM , SilvermanB , KelepourisE , et al.Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Failure Reviews2017;22(6):685-98.">Siddiqui 2017</a>; <a href="./references#CD013593-bbs2-0099" title="WobbeB , WagnerJ , SzabóDK , RostásI , FarkasN , GaramiA , et al.Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews2021;26(3):577-85.">Wobbe 2021</a>). These contradictory results were seen in our review, which is why we downgraded our evidence for the effect of UF on weight change to very low certainty.  </p> <p>At the longest available follow‐up, we found UF may have little to no impact on serum creatinine change. This is consistent with other reviews that found no significant differences in renal outcomes (<a href="./references#CD013593-bbs2-0052" title="ChenHY , ChouKJ , FangHC , ChenCL , HsuCY , HuangWC , et al.Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials. Nephron2015;129(3):189-96.">Chen 2015</a>; <a href="./references#CD013593-bbs2-0070" title="JainA , AgrawalN , KazoryA .Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Failure Reviews2016;21(5):611-9.">Jain 2016</a>; <a href="./references#CD013593-bbs2-0072" title="KwokCS , WongCW , RushtonCA , AhmedF , CunningtonC , DaviesSJ , et al.Ultrafiltration for acute decompensated cardiac failure: a systematic review and meta-analysis. International Journal of Cardiology2017;228:122-8.">Kwok 2017</a>; <a href="./references#CD013593-bbs2-0092" title="ShiX , BaoJ , ZhangH , WangH , LiL , ZhangY .Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews2019;24(6):927.">Shi 2019</a>; <a href="./references#CD013593-bbs2-0093" title="SiddiquiWJ , KohutAR , HasniSF , GoldmanJM , SilvermanB , KelepourisE , et al.Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Failure Reviews2017;22(6):685-98.">Siddiqui 2017</a>; <a href="./references#CD013593-bbs2-0099" title="WobbeB , WagnerJ , SzabóDK , RostásI , FarkasN , GaramiA , et al.Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews2021;26(3):577-85.">Wobbe 2021</a>). However, our review found the effect of UF on new initiation of dialysis maybe increased at long‐term follow‐up.  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013593-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA Study Selection" data-id="CD013593-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA Study Selection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-FIG-02" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD013593-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 1: All‐cause mortality – up to and including 30 days from discharge" data-id="CD013593-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 1: All‐cause mortality – up to and including 30 days from discharge </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 2: All‐cause mortality – longest available follow‐up" data-id="CD013593-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 2: All‐cause mortality – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 3: All‐cause rehospitalisation – up to and including 30 days from discharge" data-id="CD013593-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 3: All‐cause rehospitalisation – up to and including 30 days from discharge </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 4: All‐cause rehospitalisation – longest available follow‐up" data-id="CD013593-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 4: All‐cause rehospitalisation – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 5: Heart failure‐related rehospitalisation – up to 30 days from discharge" data-id="CD013593-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 5: Heart failure‐related rehospitalisation – up to 30 days from discharge </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 6: Heart failure‐related rehospitalisation – longest available follow‐up" data-id="CD013593-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 6: Heart failure‐related rehospitalisation – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 7: Weight change – in‐hospital follow‐up" data-id="CD013593-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 7: Weight change – in‐hospital follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 8: Hospital length of stay" data-id="CD013593-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 8: Hospital length of stay</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 9: Cardiac mortality – up to 30 days from discharge " data-id="CD013593-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 9: Cardiac mortality – up to 30 days from discharge  </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 10: Cardiac mortality – longest available follow‐up" data-id="CD013593-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 10: Cardiac mortality – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 11: Change in serum creatinine (% change from admission) – 30‐day follow‐up" data-id="CD013593-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 11: Change in serum creatinine (% change from admission) – 30‐day follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 12: Change in serum creatinine (% change from admission) – longest available follow‐up" data-id="CD013593-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 12: Change in serum creatinine (% change from admission) – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 13: New initiation of long‐term renal replacement therapy – longest available follow‐up" data-id="CD013593-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 13: New initiation of long‐term renal replacement therapy – longest available follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 14: Major bleeding (as defined by study authors) – in‐hospital" data-id="CD013593-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 14: Major bleeding (as defined by study authors) – in‐hospital </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013593-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/urn:x-wiley:14651858:media:CD013593:CD013593-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ultrafiltration versus usual care, Outcome 15: Complications of central line insertion – in‐hospital" data-id="CD013593-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_t/tCD013593-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Ultrafiltration versus usual care, Outcome 15: Complications of central line insertion – in‐hospital </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/media/CDSR/CD013593/image_n/nCD013593-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013593-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Patient or population:</b> people with AHF </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> UF </p> <p><b>Comparison:</b> UC </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with UC</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with UF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(3 to 56) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.61</b><br/>(0.13 to 2.85) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain about the effects of UF on all‐cause mortality, up to and including 30 days from discharge. </p> <p>Baseline risk (assumed control risk) for death in people with AHF within 30 days of admission taken from <a href="./references#CD013593-bbs2-0081" title="Miró Ò, RosselloX , GilV , Martín-SánchezFJ , LlorensP , Herrero-PuenteP , et al.Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Annals of Internal Medicine2017;167(10):698-705.">Miró 2017</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>124 per 1000</b> </p> <p>(91 to 169)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> </p> <p>(0.73 to 1.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>987</p> <p>(9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯ <b>Low</b><sup>b,c</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may have little to no effect on all‐cause mortality at longest available follow‐up, but the CI also includes appreciable benefit or harm. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause rehospitalisation</b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>221 per 1000</b><br/>(154 to 317) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b><br/>(0.53 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>337<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may reduce all‐cause rehospitalisation up to 30 days from discharge.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>531 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>484 per 1000</b> </p> <p>(420 to 558)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> </p> <p>(0.79 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>612</p> <p>(6 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> <p>⨁⨁◯◯ <b>Low</b><sup>b,c</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may slightly reduce all‐cause rehospitalisation at longest available follow‐up.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Heart failure‐related rehospitalisation </b> </p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to and including 30 days from discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b><br/>(67 to 184) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.62</b><br/>(0.37 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>395<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may reduce heart failure‐related rehospitalisation up to and including 30 days from discharge. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longest available follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>229 per 1000</b> </p> <p>(176 to 298)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.69</b> </p> <p>(0.53 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯ <b>Moderate</b><sup>b</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF probably reduces heart failure‐related rehospitalisation at longest available follow‐up. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Need for mechanical invasive ventilation</b> –<b> </b>up to and including 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>0 studies reported the need for mechanical ventilation, at any time point, for the comparison of UF vs UC. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>% Change in serum creatinine</b> –<b> </b> at 30 days from<b> </b>discharge </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in serum creatinine with UF at 30 days from discharge was 25% </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 14% higher</b> </p> <p>(12% lower to 40% higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>221<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may have little or no difference on serum creatinine change at 30 days from discharge. &gt; 30% serum creatinine change is clinically meaningful <a href="./references#CD013593-bbs2-0090" title="SchmidtM , MansfieldKE , BhaskaranK , NitschD , SørensenHT , SmeethL , et al.Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ (Clinical Research Ed.)2017;356:j791.">Schmidt 2017</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>New initiation of renal replacement therapy</b> –<b> </b>at longest available follow‐up </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/>(10 to 114) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.42</b><br/>(0.42 to 4.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>322<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UF may increase the risk of new initiation of renal replacement therapy. </p> <p>1 additional study reported 0 events in both arms (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>: UF = 0/15, UC = 0/15). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Complications of central line insertion</b> – in hospital </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/>(13 to 49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.16</b><br/>(1.30 to 13.30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>779<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is an uncertain effect of UF on complications from central line insertion.</p> <p>2 additional studies reported 0 events in both arms (<a href="./references#CD013593-bbs2-0006" title="GiglioliC , LandiD , CecchiE , ChiostriM , GensiniGF , ValenteS , et al.Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. European Journal of Heart Failure2011;13(3):337-46. [DOI: dx.doi.org/10.1093/eurjhf/hfq207]">Giglioli 2011</a>: UF = 0/15; UC = 0/15 and <a href="./references#CD013593-bbs2-0009" title="CosentinoER , RinaldiER , Degli EspostiD , SantiF , FerramoscaE , ColomboG , et al.Preliminary report on the effects of ultrafiltration in severe HF refractory to conventional diuretic therapy: The Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial. European Journal of Heart Failure, Supplement2011;10(Suppl 1):S112. [DOI: dx.doi.org/10.1093/eurjhf/hsr006]MarenziG , MuratoriM , CosentinoER , RinaldiER , DonghiV , MilazzoV , et al.Continuous ultrafiltration for congestive heart failure: the CUORE trial. Journal of Cardiac Failure2014;20(1):9-17. [DOI: dx.doi.org/10.1016/j.cardfail.2013.11.004]NCT00360958.Treatment of severe heart failure by ultrafiltration. clinicaltrials.gov/ct2/show/NCT00360958 (first posted 7 August 2006). ">Marenzi 2014</a>: UF = 0/27; UC = 0/29). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b>  (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHF:</b> acute heart failure; <b>CI:</b>  confidence interval; <b>MD:</b>  mean difference; <b>RCT:</b> randomised control trial; <b>RR:</b>  risk ratio; <b>UC:</b> usual care; <b>UF:</b> ultrafiltration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b>  we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b>  we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b>  our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Small sample size and low event rate, CI included no effect and also included default values for appreciable harm (CI &gt; 1.25) or appreciable benefit (CI &lt; 0.75), or both; therefore, certainty of evidence downgraded two levels for imprecision.<br/><sup>b</sup>Proportion of information from studies at high risk of bias was sufficient to lower confidence in the estimate of effect; therefore, certainty of evidence downgraded one level for methodological limitations.<br/><sup>c</sup>CI included no effect and also included default values for appreciable harm (CI &gt; 1.25) or appreciable benefit (CI &lt; 0.75), or both; therefore, certainty of evidence downgraded one level for imprecision.<br/><sup>d</sup>Small sample size and CI included no effect; therefore, certainty of evidence downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ultrafiltration (UF) compared to usual care (UC) for acute heart failure (AHF)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/full#CD013593-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013593-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Ultrafiltration versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 All‐cause mortality – up to and including 30 days from discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.13, 2.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 All‐cause mortality – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.73, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 All‐cause rehospitalisation – up to and including 30 days from discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.53, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 All‐cause rehospitalisation – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.79, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Heart failure‐related rehospitalisation – up to 30 days from discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.37, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Heart failure‐related rehospitalisation – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.53, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Weight change – in‐hospital follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [‐0.65, 4.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Hospital length of stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.78, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Cardiac mortality – up to 30 days from discharge  <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Cardiac mortality – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.53, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Change in serum creatinine (% change from admission) – 30‐day follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.12, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Change in serum creatinine (% change from admission) – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.11, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 New initiation of long‐term renal replacement therapy – longest available follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.42, 4.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Major bleeding (as defined by study authors) – in‐hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.02, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Complications of central line insertion – in‐hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.16 [1.30, 13.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Ultrafiltration versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#CD013593-tbl-0002">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-1"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 All‐cause mortality – up to and including 30 days from discharge</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2005</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a pre‐specified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All patients were followed up at 1 month and 3 months (n = 40 UF, n = 60 UC)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is objective and binary. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome is clearly reported as number and % in Table 2. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall risk of bias low across all domains. </p> </td> </tr> <tr class="study-data"> <td> <p>Shen 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear documentation of randomisation and allocation concealment noted. Baseline characteristics in table 2 show no significant differences between groups (P &gt; 0.05).  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome of mortality, is a rare but serious outcome.  2/74 eligible participants (3%) from the control group were excluded from the analysis because of ''aggravated conditions and death''. This has the potential to impact the outcome of mortality, favouring usual care.  </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While outcome data is present for &gt; 95% of participants enrolled, the outcome of mortality is a rare event. Currently, the number of events in mortality for control group is 0. Therefore, having 2/74 (3%) participants excluded from the analysis due to death/worsening health condition introduces a risk of bias.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is a binary and unambiguous outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality was robustly reported with clear cause of death specified.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Risk of bias introduced given 2/74 (3%) of eligible control participants were excluded from the statistical analysis due to worsening health conditions/deaths. This can impact the rare, but serious outcome of mortality and favours usual care.  </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 All‐cause mortality – up to and including 30 days from discharge</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-1">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-2"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.2 All‐cause mortality – longest available follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A larger proportion of patients with ischemia as a cause of AHF were included differentially in the UF group. While this could plausibly be due to chance alone, it also could be due to enrolment criteria. Given that this is an extremely important prognostic factor for AHF patients (i.e. AHF patients with acute ischemia are known to have much higher short‐term mortality and rates of other adverse outcomes), this could have led to worse outcomes in the UF patients. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There were a large degree of crossovers, and results seemed to change significantly on a post‐hoc per‐protocol analysis published years later.  An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A negligible (&lt; 5%) proportion of randomised patients were not analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective outcome, and since there is minimal LTFU, it is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis, published trial protocol available.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF.  Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All 200 randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective outcome, and since there is minimal LTFU, it is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Prespecified follow‐up was 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective outcome, and since there is minimal LTFU, it is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The prespecified clinical and safety endpoints were assessed at 30 and 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Hanna 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Baseline characteristic differences between groups not statistically significant. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients treated with intention to treat, with no crossover noted. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"A greater proportion of patients in the UF arm completed 90 days of follow‐up compared to the CD group (73.7% vs 47.1%)". The large discrepancy in follow‐up rate at 90 days could be related to the outcome. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective measurement, however since there is a significant loss to follow‐up at 90 days, it is likely that the measurement is different between the groups.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As per the NCT protocol, the intended primary and secondary outcomes are similar to what was collected. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A significant loss to follow‐up of the UC group at 90 days introduces bias when measuring long term mortality rates.  </p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All patients were followed up at 1 month and 3 months (n = 40 UF, n = 60 UC)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is objective and binary. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome is clearly reported as number and % in Table 2. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall risk of bias low across all domains. </p> </td> </tr> <tr class="study-data"> <td> <p>Marenzi 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective outcome, and since there is minimal loss to follow‐up, it is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Seker 2016</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients hospitalised for HF were randomly assigned in a 1:1 ratio", but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall some concerns as 9 additional patients enrolled in UF group were excluded due to technical difficulties, due to inadequate information about this. However, this was unlikely to affect the outcome of mortality as participants were excluded based on technical difficulties. See previous comments for more detail. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely mortality was affected by this exclusion of 9 patients due to technical difficulties. It is relatively likely that the outcome data missing is MAR, since it was largely reported to be due to difficulty with the device and interruptions due to routine clinical care."failure of a measuring device or interruptions to routine data collection” as an example of something at low risk of bias for 3.3 and 3.4.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is objective and binary. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Results were clearly reported (eg "Cardiac arrests and deaths were 40% in UF group") </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns as 9 patients initially allocated to UF group, that were then excluded due to technical difficulties (such as clotting in circuit). However, it is less likely this deviation impacted the true outcome of all cause mortality.  </p> </td> </tr> <tr class="study-data"> <td> <p>Shen 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear documentation of randomisation and allocation concealment noted. Baseline characteristics in table 2 show no significant differences between groups (P &gt; 0.05).  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome of mortality, is a rare but serious outcome. Two eligible participants (2/74 = ~3%) from the control group were excluded from the analysis because of ''aggravated conditions and death''. This has the potential to impact the outcome of mortality, favouring usual care.  </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While outcome data is present for &gt; 95% of participants enrolled, the outcome of mortality is a rare event. Currently, the number of events in mortality for control group is 0. Therefore, having 2/74 (3%) participants excluded from the analysis due to death/worsening health condition introduces a risk of bias.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is a binary and unambiguous outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality was robustly reported with clear cause of death specified. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Risk of bias introduced given 2/74 (3%) of eligible control participants were excluded from the statistical analysis due to worsening health conditions/deaths. This can impact the rare, but serious outcome of mortality and favours usual care.  </p> </td> </tr> <tr class="study-data"> <td> <p>Stein 2011</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Abstract, reported randomised but small sample size of 10 and baseline characteristics are not included. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear from the abstract if there were deviations from the interventions.</p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While not explicitly reported if loss to follow up, all patients appeared to have been followed up.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Mortality is an objective outcome, and since there is minimal loss to follow‐up, it is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unclear if prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns due to lack of information, small study size and unclear reporting. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.2 All‐cause mortality – longest available follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-2">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-3"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.3 All‐cause rehospitalisation – up to and including 30 days from discharge</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Chung 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, there is no reason to suspect concealment was not implemented appropriately. It is likely these details were omitted for word‐count purposes. A lower haematocrit in the UF group could be due to poor randomization, but is most likely due to chance alone, especially given such a small sample size.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear if there was a prespecified analysis plan, however there is generally only one unambiguous way to measure this outcome. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There was some concern of selection bias as unclear if a pre‐specified analysis plan was used.  </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The prespecified clinical and safety endpoints were assessed at 30 and 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All patients were followed up at 1 month and 3 months (n = 40 UF, n = 60 UC)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Rehospitalisation is objectively measured. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome is clearly reported as number and % in Table 2. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall risk of bias low across all domains. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.3 All‐cause rehospitalisation – up to and including 30 days from discharge</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-3">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-4"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.4 All‐cause rehospitalisation – longest available follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A larger proportion of patients with ischemia as a cause of AHF were included differentially in the UF group. While this could plausibly be due to chance alone, it also could be due to enrolment criteria. Given that this is an extremely important prognostic factor for AHF patients (i.e. AHF patients with acute ischemia are known to have much higher short‐term mortality and rates of other adverse outcomes), this could have led to worse outcomes in the UF patients. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There were a large degree of crossovers, and results seemed to change significantly on a post‐hoc per‐protocol analysis published years later.  An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A negligible (&lt;5%) proportion of randomized patients were not analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely for bias given objective measurement of rehospitalisation and LTFU is minimal.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis, published trial protocol available.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Chung 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, there is no reason to suspect concealment was not implemented appropriately. It is likely these details were omitted for word‐count purposes. A lower haematocrit in the UF group could be due to poor randomization, but is most likely due to chance alone, especially given such a small sample size.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely bias given rehospitalisation is objective, and loss to follow up is minimal.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear if there was a prespecified analysis plan, however there is generally only one unambiguous way to measure this outcome. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There was some concern of selection bias as unclear if a pre‐specified analysis plan was used. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomized patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation since rehospitalisation is an objective outcome, and loss to follow‐up was minimal.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The prespecified clinical and safety endpoints were assessed at 30 and 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Hanna 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Baseline characteristic differences between groups not statistically significant. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients treated with intention to treat, with no crossover noted. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"A greater proportion of patients in the UF arm completed 90days of follow‐up compared to the CD group (73.7% vs 47.1%)". The large discrepancy in follow‐up rate at 90 days could be related to the outcome. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Rehospitalisation is an objective measurement, however since there is a significant loss to follow‐up at 90 days, it is likely that the measurement is different between the groups.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As per the NCT protocol, the intended primary and secondary outcomes are similar to what was collected </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A significant loss to follow‐up of the UC group at 90days introduces bias when measuring long term rehospitalisation rates.  </p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All patients were followed up at 1 month and 3 months (n = 40 UF, n = 60 UC).</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Rehospitalisation is objectively measured. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome is clearly reported as number and % in Table 2. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall risk of bias low across all domains. </p> </td> </tr> <tr class="study-data"> <td> <p>Marenzi 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>At the longest available follow‐up, more than 20% missing outcome data in both groups. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Rehospitalisation is an objective measurement, however since there is a significant loss to follow‐up at 90 days, it is likely that the measurement is different between the groups.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis. Pre‐specified time points used ''complete clinical examination, with particular attention to body weight and fluid balance, was performed at baseline, daily, at discharge and 1‐year followup". </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A significant loss to follow‐up in both the groups at 90 days introduces bias when measuring long term rehospitalisation rates.  </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.4 All‐cause rehospitalisation – longest available follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-4">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-5"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.5 Heart failure‐related rehospitalisation – up to 30 days from discharge</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Prespecified followup was 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The prespecified clinical and safety endpoints were assessed at 30 and 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.5 Heart failure‐related rehospitalisation – up to 30 days from discharge</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-5">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-6"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.6 Heart failure‐related rehospitalisation – longest available follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A larger proportion of patients with ischemia as a cause of AHF were included differentially in the UF group. While this could plausibly be due to chance alone, it also could be due to enrolment criteria. Given that this is an extremely important prognostic factor for AHF patients (i.e. AHF patients with acute ischemia are known to have much higher short‐term mortality and rates of other adverse outcomes), this could have led to worse outcomes in the UF patients. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There were a large degree of crossovers, and results seemed to change significantly on a post‐hoc per‐protocol analysis published years later.  An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A negligible (&lt; 5%) proportion of randomised patients were not analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation since rehospitalisation is an objective outcome, and loss to follow‐up was minimal.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis, published trial protocol available.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All 200 randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation since rehospitalisation is an objective outcome, and loss to follow‐up was minimal.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation since rehospitalisation is an objective outcome, and loss to follow‐up was minimal.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The prespecified clinical and safety endpoints were assessed at 30 and 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Marenzi 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation since rehospitalisation is an objective outcome, and loss to follow‐up was minimal.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis. Pre‐specified time points used ''complete clinical examination, with particular attention to body weight and fluid balance, was performed at baseline, daily, at discharge and 1‐year followup". </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.6 Heart failure‐related rehospitalisation – longest available follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-6">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-7"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.7 Weight change – in‐hospital follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2005</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Weight loss were obtained by research personnel at baseline and 24h using the same scale with the patient shoeless in a hospital gown". </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Bart 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A larger proportion of patients with ischemia as a cause of AHF were included differentially in the UF group. While this could plausibly be due to chance alone, it also could be due to enrolment criteria. Given that this is an extremely important prognostic factor for AHF patients (i.e. AHF patients with acute ischemia are known to have much higher short‐term mortality and rates of other adverse outcomes), this could have led to worse outcomes in the UF patients. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There were a large degree of crossovers, and results seemed to change significantly on a post‐hoc per‐protocol analysis published years later.  An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A negligible proportion (&lt; 5%) of randomised patients were not analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Objective weight loss measured at pre‐specified end point 96 hours.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis, published trial protocol available.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Chung 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, there is no reason to suspect concealment was not implemented appropriately. It is likely these details were omitted for word‐count purposes. A lower haematocrit in the UF group could be due to poor randomization, but is most likely due to chance alone, especially given such a small sample size.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Targeted weight loss was prospectively calculated based on chart review and clinical details, or using a preset algorithm. "Weights were recorded each morning, after voiding, using the same scale and wearing similar clothing". </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear if there was a prespecified analysis plan, however there is generally only one unambiguous way to measure this outcome. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There was some concern of selection bias as unclear if a pre‐specified analysis plan was used. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The NCT trial protocol published 2005 shows weight loss was a primary outcome. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐specified time point was determined (72 hours) and unlikely this objective measurement was different between the two group.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A high risk of bias in deviations from intended interventions was seen due to crossover. This would be expected to favour UC rather than UF. Thus, this would be expected to skew results towards the null. </p> </td> </tr> <tr class="study-data"> <td> <p>Giglioli 2011</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While method of randomisation not detailed, it is published in a large peer reviewed journal with word count limits. Baseline characteristics are similar between groups. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In both groups, no additional interventions such as inotropes were required or crossover done. While not explicitly stated, this is a short 36‐hour study, so patients were likely analysed in an intention to treat manner.  </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data largely available for all patients, short study of 36 hours when low risk of loss to follow‐up.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias as physical assessments made pre‐treatment and at 36 hours.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Weight recorded at various time‐points but reported for both groups at baseline, end of treatment and 36 hours, so unlikely selection bias. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall low risk of bias. </p> </td> </tr> <tr class="study-data"> <td> <p>Hanna 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Baseline characteristic differences between groups not statistically significant. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients treated with intention to treat, with no crossover noted. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Slightly increased missing data in usual care at long term follow up, but would not affect in‐hospital measurement of weight loss.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While how weight was recorded is not detailed, it is measured objectively in kg.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As per the NCT protocol, the intended primary and secondary outcomes are similar to what was collected. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data for weight loss is available for all patients randomised. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While how weight was recorded is not detailed, it is measured objectively in kg. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome is clearly reported, at prespecified time points of admission, day 3 and day 8. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall risk of bias low across all domains. </p> </td> </tr> <tr class="study-data"> <td> <p>Marenzi 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Objective measurement of weight loss.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis. Pre‐specified time points used ''complete clinical examination, with particular attention to body weight and fluid balance, was performed at baseline, daily, at discharge and 1‐year followup". </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Sav 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col10" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomly assigned in 1:1 ratio." No other explicit statements. However, there do not appear to be differences in the groups that would bias the results. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No crossovers.</p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In‐hospital study with no lost‐to‐follow‐up.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Objective weight loss, while unclear if same calibrated scales used, the study details other measurement outcomes with care (e.g. echo done by same operator) to minimise measurement bias.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"End of study" for weight change can be variable, and is not clearly defined. Duration of intervention (UF vs Furosemide) was also variable at 12 to 13 days, further increasing the chance that the comparison is biased by the time of measurement. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of selection bias as no prespecified time point of when weight change will be measured at.  </p> </td> </tr> <tr class="study-data"> <td> <p>Shen 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear documentation of randomisation and allocation concealment noted. Baseline characteristics in table 2 show no significant differences between groups (P &gt; 0.05).  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>2 eligible participants (2/74 = ~3%) from the control group were excluded from the analysis because of ''aggravated conditions and death''. However, this is a small % for an outcome such as weight loss where the exclusions are not strongly related. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome data is present for &gt; 95% of participants enrolled. While 2/74 (3%)participants excluded from the analysis, this is a small number of missing data for this continuous outcome, and unlikely weight loss is truly influenced by this.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While there is no clear documentation of how weight loss was measured and there can be minor variance, it is still an objective measurement.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Weight loss is clearly and robustly reported in Table 4 ‐ from beginning to end of treatment.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns of bias introduced given 2/74 (3%) of eligible control participants were excluded from the statistical analysis due to worsening health conditions/deaths. However, this is less likely to affect the continuous outcome of weight loss.  </p> </td> </tr> <tr class="study-data"> <td> <p>Stein 2011</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Abstract, reported randomised but small sample size of 10 and baseline characteristics are not included. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear from the abstract if there were deviations from the interventions.</p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While not explicitly reported if loss to follow up, all patients appeared to have been followed up.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Not clearly specified, but objective weight measurement.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No mention of protocol. No pre‐specified time point for weight change, which could lead to selection bias.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns due to lack of information, small study size and unclear reporting. </p> </td> </tr> <tr class="study-data"> <td> <p>Tabak'ian 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>See Table 1. As per translator and text "no significant differences between two groups at baselines on age and most of the parameters". </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Difficult to ascertain due to language barrier, but data extraction by translator doesn't suggest additional interventions needed, and all patients analysed in group they were randomised in.  </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Weight loss is an objective outcome.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Weight loss measured at baseline and ''end of CHF compensation'' without detailing what this means, rather than using an objective time‐point for this outcome. Could lead to selection bias, as weight is often used to guide treatment.  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Bias introduced in the selection of reported results raises some concerns, for which the directionality of the bias is indeterminate.  </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.7 Weight change – in‐hospital follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-7">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-8"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.13 New initiation of long‐term renal replacement therapy – longest available follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context.  However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomized patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Measurement appears appropriate for the outcome, and is unlikely to be influenced by group allocation. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Prespecified followup was 90 days". It appears that this was most likely a prespecified analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Hanna 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Baseline characteristic differences between groups not statistically significant. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients treated with intention to treat, with no crossover noted. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Slightly increased missing data in usual care but unlikely to affect renal replacement therapy outcome.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely for bias given objective measurement of new dialysis. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As per the NCT protocol, the intended primary and secondary outcomes are similar to what was collected. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Marenzi 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely for bias given objective measurement of new dialysis. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>The risk of bias was low in all domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Seker 2016</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients hospitalised for HF were randomly assigned in a 1:1 ratio", but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall some concerns as 9 additional patients enrolled in UF group were excluded due to technical difficulties, due to inadequate information about this. However, this was unlikely to affect the outcome of need for dialysis as participants were excluded based on technical difficulties.  </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unlikely need for dialysis was affected by this exclusion of 9 patients due to technical difficulties. It is relatively likely that the outcome data missing is MAR, since it was largely reported to be due to difficulty with the device and interruptions due to routine clinical care."failure of a measuring device or interruptions to routine data collection” as an example of something at low risk of bias for 3.3 and 3.4.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Need for haemodialysis is objective and binary. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Results were clearly reported (e.g. 5% of usual care required haemodialysis)</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns as 9 patients initially allocated to UF group, that were then excluded due to technical difficulties (such as clotting in circuit). It is unlikely that this deviation actually impacted the true outcome need for haemodialysis.  </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.13 New initiation of long‐term renal replacement therapy – longest available follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-8">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-9"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.15 Complications of central line insertion – in‐hospital</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Bart 2005</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Central line complications are more likely to be noticed in the UF group given that the intervention was unblinded, and the UC group would be unlikely to have central lines. It seems likely based on the text that such knowledge in this case did increase detection of such complications. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It is unclear if measurement of central line complications were an a priori outcome, and if so what criteria for measurement were used. Given that multiple complications assessed in multiple ways are possible, there is some concern of bias here. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all of the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results to favor UC. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>An intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. However, no significant signs of crossover or other deviations arising due to the trial context are suspected. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Central line complications are more likely to be noticed in the UF group given that the intervention was unblinded, and the UC group would be unlikely to have central lines. However, it is unlikely that this influenced outcome assessment given the numbers noted and the expected direction of effect if an adverse effect on outcomes did occur. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards UC. </p> </td> </tr> <tr class="study-data"> <td> <p>Costanzo 2015</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>States only that this was a randomised trial, without mentioning concealment. However, this was conducted by an experienced investigator and clinical trial network. It is likely these details were omitted for word‐count purposes. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Crossovers were noted. With an intervention like UF, which is unblinded and requires invasive venous access not necessarily obtained in the comparator group, raises the possibility that patients or physicians could have differentially crossed‐over due to the trial context. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All randomised patients were analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Central line complications are more likely to be noticed in the UF group given that the intervention was unblinded, and the UC group would be unlikely to have central lines. However, it is unlikely that this influenced outcome assessment given the numbers noted and the expected direction of effect if an adverse effect on outcomes did occur. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards UC. </p> </td> </tr> <tr class="study-data"> <td> <p>Bart 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A larger proportion of patients with ischemia as a cause of AHF were included differentially in the UF group. While this could plausibly be due to chance alone, it also could be due to enrolment criteria. Given that this is an extremely important prognostic factor for AHF patients (i.e. AHF patients with acute ischemia are known to have much higher short‐term mortality and rates of other adverse outcomes), this could have led to worse outcomes in the UF patients. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>There were a large degree of crossovers, and results seemed to change significantly on a post‐hoc per‐protocol analysis published years later. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>A negligible (&lt; 5%) proportion of randomised patients were not analysed.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Central line complications are more likely to be noticed in the UF group given that the intervention was unblinded, and the UC group would be unlikely to have central lines. However, it is unlikely that this influenced outcome assessment given the numbers noted and the expected direction of effect if an adverse effect on outcomes did occur. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>It appears that this was most likely a prespecified analysis.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>In all the domains with a greater than "low" risk of bias, it would be expected that the specific bias would favour UC rather than UF. Thus, this would be expected to skew results towards UC. </p> </td> </tr> <tr class="study-data"> <td> <p>Seker 2016</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients hospitalised for HF were randomly assigned in a 1:1 ratio", but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall high risk as 9 additional patients enrolled in UF group were excluded due to technical difficulties, due to inadequate information about this. See previous comments for more detail. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias as all missing data is from the 9 enrolled in UF group due to technical issues ‐ this could reflect true outcome data as that technical issue could be from complications of central line.  </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While it is unlikely that the outcome of complications from central line was affected by lack of blinding, it is still possible. How the complications were measured for Pneumothorax/infection is also not documented and is clinician dependent. Thus, there are some concerns of the risk of bias.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Complication were relatively robustly reported (e.g. "bleeding or infection" were reported).  </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Risk of bias arises from 9 patients initially allocated to UF group, that were then excluded due to technical difficulties (such as clotting in circuit). However, this deviation from protocol could have reflected true changes in the outcome of complications from central line.  </p> </td> </tr> <tr class="study-data"> <td> <p>Hu 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Patients were randomised after clinical evaluation" but the method of randomisation not clearly stated, might be dropped for word count. No evidence of selection bias as Table 1 shows no statistically significant differences between baseline characteristics of 2 groups.  </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No significant deviations from intended protocol seen. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All patients were followed up for this in hospital outcome. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While it is unlikely that the outcome of complications from central line was affected by lack of blinding, it is still possible. How the complications were measured for Pneumothorax/infection is also not documented and is clinician dependent. Thus, there are some concerns of the risk of bias.  </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Table 3 clearly reports safety end points that are related to central line.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall some concerns about bias arising from unblinded nature of outcome measurement. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.15 Complications of central line insertion – in‐hospital</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013593.pub2/references#riskOfBias2Table-9">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013593.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013593-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013593-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013593-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD013593-note-0008">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013593-note-0006">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013593-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013593-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013593-note-0005">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013593\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013593\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013593\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013593\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013593\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013593.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013593.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013593.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013593.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013593.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725010313"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013593.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725010316"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013593.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e70c8c9351bdf',t:'MTc0MDcyNTAxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 